linghui personal page - To The Moon

linghui

No personal profile

3Follow

0Followers

0Topic

0Badge

2022-02-14

Great ariticle, would you like to share it?

@OptionPlus:Option Recap: Don't take chestnuts out of the fire

2022-02-10

sigh

@BaronLyly:$Marathon Digital Holdings Inc(MARA)$ you won’t see much growth here . You should be banking on FRTTF$FORTRESS TECHNOLOGIES INC.(FRTTF)$ and LUXXF$LUXXFOLIO HLDGS INC(LUXFF)$ as they will double , triple and very cheap . I bought MARA and RIOT$Riot Blockchain, Inc.(RIOT)$ as a penny stock last year so jump on same. Easier to double and triple your money if you buy low hanging fruit .looks like accumulation before the next leg up

2022-02-05

Ok

Apple Aims to Debut a New Low-Cost 5G iPhone and iPad in Early March

2022-02-05

Ok

Metauniverse Stocks Slid in Premarket Trading,With Block and Roblox Falling Over 6%

2022-02-03

Ok

10 Biggest Price Target Changes For Wednesday

2022-02-03

Thanks

2 Biotech Stocks That Could Make You Richer

2022-02-02

Ok

AT&T Is Getting Closer to a Clean Slate. Here’s What Comes Next

2022-02-02

Ok

Starbucks Shares Down 1% on Q4 EPS Miss; Revenues Better Than Expected

2022-02-02

Gd info

MicroStrategy shares rose 7% in premarket trading

2022-02-02

Above ok!

5 High-Yield Dividend Stocks That Can Save Your Portfolio During a Stock Market Crash

2022-02-02

Ok

Wall St Posts Gains after Choppy Session, Energy Index Hits New Peak

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3582933493509774","uuid":"3582933493509774","gmtCreate":1619839469204,"gmtModify":1706397937718,"name":"linghui","pinyin":"linghui","introduction":"","introductionEn":"","signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":3,"tweetSize":11,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.01.30","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001}],"userBadgeCount":1,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":9095302361,"gmtCreate":1644813840775,"gmtModify":1676533964421,"author":{"id":"3582933493509774","authorId":"3582933493509774","name":"linghui","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582933493509774","authorIdStr":"3582933493509774"},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9095302361","repostId":"9092755406","repostType":1,"repost":{"id":9092755406,"gmtCreate":1644742715482,"gmtModify":1676533958368,"author":{"id":"3527667591235607","authorId":"3527667591235607","name":"OptionPlus","avatar":"https://static.tigerbbs.com/e8009c23927adcf8b5e1e1d101178392","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3527667591235607","authorIdStr":"3527667591235607"},"themes":[],"title":"Option Recap: Don't take chestnuts out of the fire","htmlText":"The general idea is similar to last week, so I dont do detailed review，you can read&nbsp;my&nbsp;review&nbsp;for&nbsp;last&nbsp;week&nbsp;if&nbsp;you&nbsp;like. The&nbsp;S&amp;P&nbsp;500&nbsp;fell&nbsp;be&nbsp;its&nbsp;anual&nbsp;support&nbsp;line&nbsp;again&nbsp;in&nbsp;the&nbsp;second&nbsp;half&nbsp;of&nbsp;Friday&nbsp;night&nbsp;with&nbsp;geopolitical shocks.&nbsp;And&nbsp;It&nbsp;closed&nbsp;at&nbsp;a&nbsp;weely&nbsp;low&nbsp;point.&nbsp;My&nbsp;feeling&nbsp;is&nbsp;similar&nbsp;to&nbsp;last&nbsp;week,&nbsp;it&nbsp;might&nbsp;draw&nbsp;a&nbsp;right-leg. There&nbsp;is&nbsp;a&nbsp;small&nbsp;double-top&nbsp;in&nbsp;past&nbsp;two&nbsp;weeks,&nbsp;and&nbsp;both&nbsp;small&nbsp;tops&nbsp;did&nbsp;not&nbsp;rally&nbsp;to&nbsp;the&nbsp;MA50,&nbsp;it&nbsp;was&nbsp;not&nbsp;strong.&nbsp;As&nbsp;","listText":"The general idea is similar to last week, so I dont do detailed review，you can read&nbsp;my&nbsp;review&nbsp;for&nbsp;last&nbsp;week&nbsp;if&nbsp;you&nbsp;like. The&nbsp;S&amp;P&nbsp;500&nbsp;fell&nbsp;be&nbsp;its&nbsp;anual&nbsp;support&nbsp;line&nbsp;again&nbsp;in&nbsp;the&nbsp;second&nbsp;half&nbsp;of&nbsp;Friday&nbsp;night&nbsp;with&nbsp;geopolitical shocks.&nbsp;And&nbsp;It&nbsp;closed&nbsp;at&nbsp;a&nbsp;weely&nbsp;low&nbsp;point.&nbsp;My&nbsp;feeling&nbsp;is&nbsp;similar&nbsp;to&nbsp;last&nbsp;week,&nbsp;it&nbsp;might&nbsp;draw&nbsp;a&nbsp;right-leg. There&nbsp;is&nbsp;a&nbsp;small&nbsp;double-top&nbsp;in&nbsp;past&nbsp;two&nbsp;weeks,&nbsp;and&nbsp;both&nbsp;small&nbsp;tops&nbsp;did&nbsp;not&nbsp;rally&nbsp;to&nbsp;the&nbsp;MA50,&nbsp;it&nbsp;was&nbsp;not&nbsp;strong.&nbsp;As&nbsp;","text":"The general idea is similar to last week, so I dont do detailed review，you can read my review for last week if you like. The S&P 500 fell be its anual support line again in the second half of Friday night with geopolitical shocks. And It closed at a weely low point. My feeling is similar to last week, it might draw a right-leg. There is a small double-top in past two weeks, and both small tops did not rally to the MA50, it was not strong. As","images":[{"img":"https://static.tigerbbs.com/ed0379ee21b4ee0665a09e0210e754a4","width":"2096","height":"1220"},{"img":"https://static.tigerbbs.com/cbe5974fdf018ff5b17c62544ec1de99","width":"2144","height":"1534"},{"img":"https://static.tigerbbs.com/cc0af868946c5e3165b2c5dad80913e6","width":"2198","height":"1332"}],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9092755406","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":3,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":476,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9092993723,"gmtCreate":1644504373762,"gmtModify":1676533934446,"author":{"id":"3582933493509774","authorId":"3582933493509774","name":"linghui","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582933493509774","authorIdStr":"3582933493509774"},"themes":[],"htmlText":"sigh","listText":"sigh","text":"sigh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9092993723","repostId":"696619638","repostType":1,"repost":{"id":696619638,"gmtCreate":1640679651873,"gmtModify":1676532477490,"author":{"id":"9000000000000695","authorId":"9000000000000695","name":"BaronLyly","avatar":"https://static.tigerbbs.com/2002537f0b7be973a9a9a72fea618459","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"9000000000000695","authorIdStr":"9000000000000695"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MARA\">$Marathon Digital Holdings Inc(MARA)$</a> you won’t see much growth here . You should be banking on FRTTF<a href=\"https://laohu8.com/S/FRTTF\">$FORTRESS TECHNOLOGIES INC.(FRTTF)$</a> and LUXXF<a href=\"https://laohu8.com/S/LUXFF\">$LUXXFOLIO HLDGS INC(LUXFF)$</a> as they will double , triple and very cheap . I bought MARA and RIOT<a href=\"https://laohu8.com/S/RIOT\">$Riot Blockchain, Inc.(RIOT)$</a> as a penny stock last year so jump on same. Easier to double and triple your money if you buy low hanging fruit .looks like accumulation before the next leg up","listText":"<a href=\"https://laohu8.com/S/MARA\">$Marathon Digital Holdings Inc(MARA)$</a> you won’t see much growth here . You should be banking on FRTTF<a href=\"https://laohu8.com/S/FRTTF\">$FORTRESS TECHNOLOGIES INC.(FRTTF)$</a> and LUXXF<a href=\"https://laohu8.com/S/LUXFF\">$LUXXFOLIO HLDGS INC(LUXFF)$</a> as they will double , triple and very cheap . I bought MARA and RIOT<a href=\"https://laohu8.com/S/RIOT\">$Riot Blockchain, Inc.(RIOT)$</a> as a penny stock last year so jump on same. Easier to double and triple your money if you buy low hanging fruit .looks like accumulation before the next leg up","text":"$Marathon Digital Holdings Inc(MARA)$ you won’t see much growth here . You should be banking on FRTTF$FORTRESS TECHNOLOGIES INC.(FRTTF)$ and LUXXF$LUXXFOLIO HLDGS INC(LUXFF)$ as they will double , triple and very cheap . I bought MARA and RIOT$Riot Blockchain, Inc.(RIOT)$ as a penny stock last year so jump on same. Easier to double and triple your money if you buy low hanging fruit .looks like accumulation before the next leg up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/696619638","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":855,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9098309708,"gmtCreate":1644020507382,"gmtModify":1676533881869,"author":{"id":"3582933493509774","authorId":"3582933493509774","name":"linghui","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582933493509774","authorIdStr":"3582933493509774"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9098309708","repostId":"2209345239","repostType":4,"repost":{"id":"2209345239","kind":"news","pubTimestamp":1644016922,"share":"https://ttm.financial/m/news/2209345239?lang=&edition=fundamental","pubTime":"2022-02-05 07:22","market":"us","language":"en","title":"Apple Aims to Debut a New Low-Cost 5G iPhone and iPad in Early March","url":"https://stock-news.laohu8.com/highlight/detail?id=2209345239","media":"Bloomberg","summary":"Apple Inc. is targeting a date on or near March 8 to unveil a new low-cost iPhone and an updated iPad, according to people with knowledge of the matter, kicking off a potentially record-setting year f","content":"<html><head></head><body><p>Apple Inc. is targeting a date on or near March 8 to unveil a new low-cost iPhone and an updated iPad, according to people with knowledge of the matter, kicking off a potentially record-setting year for product launches.</p><p>The announcement will mark Apple’s first major event since a new MacBook Pro debuted in October. Like the company’s other recent launches, it’s expected to be an online presentation rather than in-person, said the people, who asked not to be identified because the deliberations are private.</p><p>Apple is coming off a holiday quarter that far exceeded Wall Street predictions, helping quell fears that supply-chain problems would hurt sales. Now the company is setting its sights higher for 2022. The March announcements -- along with the usual flood of product news expected later in 2022 -- suggest Apple will introduce its biggest crop of new devices ever in a single year.</p><p>Given that the planned timing is still more than a month away, the company’s plans may change in the face of production delays or other changes, the people said. An Apple spokeswoman declined to comment on the company’s plans.</p><p>The new phone will be the first update to the iPhone SE model in two years, adding 5G network capabilities, an improved camera and a faster processor. But the design itself is expected to be similar to the current version, which debuted in April 2020.</p><p>The new iPad, meanwhile, will be an update to the Air model that features a faster processor and 5G. The company is also planning a new Mac with Apple-designed chips, which could also come as early as March.</p><p>In addition to announcing new devices, the company is planning to release iOS 15.4 in the first half of March, the people said. The software update will add Face ID support for people wearing masks to iPhones and iPads, making it easier for users to unlock their devices. It also has new emojis and Universal Control, which lets customers use a single keyboard and trackpad across multiple iPads and Macs.</p><p>Following the March event, the company will likely hold its annual Worldwide Developers Conference in June to announce software updates for the iPhone, iPad, Mac and Apple Watch. It’s then expected to hold multiple keynote events in the fall to launch the iPhone 14 and new Macs.</p><p>The 2022 lineup is likely to include new iMac and Mac Pro desktops, a redesigned MacBook Air, an updated low-end MacBook Pro, three Apple Watches, four iPhone 14 models and new AirPods. The company is also planning new services, such as a feature that lets the iPhone accept payments with the tap of a credit card.</p><p>Apple is working on a high-end mixed reality headset as well, but that’s now more likely to be released in 2023. The company had aimed to announce the device as early as the end of 2022, but development challenges have delayed the timing, Bloomberg reported last month.</p></body></html>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple Aims to Debut a New Low-Cost 5G iPhone and iPad in Early March</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple Aims to Debut a New Low-Cost 5G iPhone and iPad in Early March\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-05 07:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/apple-aims-debut-low-cost-193822024.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Apple Inc. is targeting a date on or near March 8 to unveil a new low-cost iPhone and an updated iPad, according to people with knowledge of the matter, kicking off a potentially record-setting year ...</p>\n\n<a href=\"https://finance.yahoo.com/news/apple-aims-debut-low-cost-193822024.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NGD":"New Gold","BK4527":"明星科技股","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4550":"红杉资本持仓","AAPL":"苹果","BK4554":"元宇宙及AR概念","BK4566":"资本集团","BK4515":"5G概念","BK4532":"文艺复兴科技持仓","BK4501":"段永平概念","BK4505":"高瓴资本持仓","BK4553":"喜马拉雅资本持仓","BK4507":"流媒体概念","BK4170":"电脑硬件、储存设备及电脑周边","BK4559":"巴菲特持仓","BK4017":"黄金","BK4534":"瑞士信贷持仓"},"source_url":"https://finance.yahoo.com/news/apple-aims-debut-low-cost-193822024.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2209345239","content_text":"Apple Inc. is targeting a date on or near March 8 to unveil a new low-cost iPhone and an updated iPad, according to people with knowledge of the matter, kicking off a potentially record-setting year for product launches.The announcement will mark Apple’s first major event since a new MacBook Pro debuted in October. Like the company’s other recent launches, it’s expected to be an online presentation rather than in-person, said the people, who asked not to be identified because the deliberations are private.Apple is coming off a holiday quarter that far exceeded Wall Street predictions, helping quell fears that supply-chain problems would hurt sales. Now the company is setting its sights higher for 2022. The March announcements -- along with the usual flood of product news expected later in 2022 -- suggest Apple will introduce its biggest crop of new devices ever in a single year.Given that the planned timing is still more than a month away, the company’s plans may change in the face of production delays or other changes, the people said. An Apple spokeswoman declined to comment on the company’s plans.The new phone will be the first update to the iPhone SE model in two years, adding 5G network capabilities, an improved camera and a faster processor. But the design itself is expected to be similar to the current version, which debuted in April 2020.The new iPad, meanwhile, will be an update to the Air model that features a faster processor and 5G. The company is also planning a new Mac with Apple-designed chips, which could also come as early as March.In addition to announcing new devices, the company is planning to release iOS 15.4 in the first half of March, the people said. The software update will add Face ID support for people wearing masks to iPhones and iPads, making it easier for users to unlock their devices. It also has new emojis and Universal Control, which lets customers use a single keyboard and trackpad across multiple iPads and Macs.Following the March event, the company will likely hold its annual Worldwide Developers Conference in June to announce software updates for the iPhone, iPad, Mac and Apple Watch. It’s then expected to hold multiple keynote events in the fall to launch the iPhone 14 and new Macs.The 2022 lineup is likely to include new iMac and Mac Pro desktops, a redesigned MacBook Air, an updated low-end MacBook Pro, three Apple Watches, four iPhone 14 models and new AirPods. The company is also planning new services, such as a feature that lets the iPhone accept payments with the tap of a credit card.Apple is working on a high-end mixed reality headset as well, but that’s now more likely to be released in 2023. The company had aimed to announce the device as early as the end of 2022, but development challenges have delayed the timing, Bloomberg reported last month.","news_type":1},"isVote":1,"tweetType":1,"viewCount":469,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9098309592,"gmtCreate":1644020478679,"gmtModify":1676533881861,"author":{"id":"3582933493509774","authorId":"3582933493509774","name":"linghui","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582933493509774","authorIdStr":"3582933493509774"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9098309592","repostId":"1133568920","repostType":4,"repost":{"id":"1133568920","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1643879102,"share":"https://ttm.financial/m/news/1133568920?lang=&edition=fundamental","pubTime":"2022-02-03 17:05","market":"us","language":"en","title":"Metauniverse Stocks Slid in Premarket Trading,With Block and Roblox Falling Over 6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1133568920","media":"Tiger Newspress","summary":"Metauniverse stocks slid in premarket trading, with Block and Roblox falling over6%.In Meta’s financ","content":"<html><head></head><body><p>Metauniverse stocks slid in premarket trading, with Block and Roblox falling over6%.</p><p><img src=\"https://static.tigerbbs.com/9bf35520675a25a430afdadb73298193\" tg-width=\"287\" tg-height=\"191\" referrerpolicy=\"no-referrer\"/></p><p>In Meta’s financial result ,it disclosed the data of FRL department including metauniverse strategy for the first time. The company expected that the investment in metauniverse will reduce the operating profit by about US $10 billion in 2021, and FRL will not make a profit in the short term.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Metauniverse Stocks Slid in Premarket Trading,With Block and Roblox Falling Over 6%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMetauniverse Stocks Slid in Premarket Trading,With Block and Roblox Falling Over 6%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-02-03 17:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Metauniverse stocks slid in premarket trading, with Block and Roblox falling over6%.</p><p><img src=\"https://static.tigerbbs.com/9bf35520675a25a430afdadb73298193\" tg-width=\"287\" tg-height=\"191\" referrerpolicy=\"no-referrer\"/></p><p>In Meta’s financial result ,it disclosed the data of FRL department including metauniverse strategy for the first time. The company expected that the investment in metauniverse will reduce the operating profit by about US $10 billion in 2021, and FRL will not make a profit in the short term.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"RBLX":"Roblox Corporation","SQ":"Block"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1133568920","content_text":"Metauniverse stocks slid in premarket trading, with Block and Roblox falling over6%.In Meta’s financial result ,it disclosed the data of FRL department including metauniverse strategy for the first time. The company expected that the investment in metauniverse will reduce the operating profit by about US $10 billion in 2021, and FRL will not make a profit in the short term.","news_type":1},"isVote":1,"tweetType":1,"viewCount":466,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9091661999,"gmtCreate":1643853421813,"gmtModify":1676533863822,"author":{"id":"3582933493509774","authorId":"3582933493509774","name":"linghui","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582933493509774","authorIdStr":"3582933493509774"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9091661999","repostId":"1178657302","repostType":4,"repost":{"id":"1178657302","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1643804908,"share":"https://ttm.financial/m/news/1178657302?lang=&edition=fundamental","pubTime":"2022-02-02 20:28","market":"us","language":"en","title":"10 Biggest Price Target Changes For Wednesday","url":"https://stock-news.laohu8.com/highlight/detail?id=1178657302","media":"Benzinga","summary":"Keybanc lifted the price target for Alphabet Inc. from $3,090 to $3,400. Alphabet shares surged 11% ","content":"<html><head></head><body><ul><li>Keybanc lifted the price target for <b>Alphabet Inc.</b> from $3,090 to $3,400. Alphabet shares surged 11% to $3,055.00 in pre-market trading.</li><li>Wedbush cut the price target on <b>Starbucks Corporation</b> from $110 to $106. Starbucks shares fell 2.5% to $96.29 in pre-market trading.</li><li>Cowen &amp; Co. cut <b>Clover Health Investments, Corp.</b> price target from $7 to $3. Clover Health Investments shares rose 6.5% to $2.97 in pre-market trading.</li><li>UBS lowered <b>Zimmer Biomet Holdings, Inc.</b> price target from $172 to $130. Zimmer Biomet shares fell 0.2% to $123.80 in pre-market trading.</li><li>Citigroup cut <b>loanDepot, Inc.</b> price target from $12 to $5. loanDepot shares fell 4.9% to close at $4.46 on Tuesday.</li></ul><ul><li>Raymond James boosted the price target for <b>NXP Semiconductors N.V.</b> from $250 to $260. NXP Semiconductors shares rose 1.4% to $211.10 in pre-market trading.</li><li>SVB Leerink raised the price target on <b>Bio-Techne Corporation</b> from $530 to $575. Bio-Techne shares rose 0.1% to $401.76 in pre-market trading.</li><li>Goldman Sachs lowered <b>2U, Inc.</b> price target from $42 to $25. 2U shares rose 6.7% to $17.79 in pre-market trading.</li><li>UBS cut the price target on <b>Etsy, Inc.</b> from $215 to $180. Etsy shares rose 2% to $155.16 in pre-market trading.</li><li>Keybanc cut <b>PayPal Holdings, Inc.</b> price target from $250 to $200. PayPal shares fell 16% to $148.00 in pre-market trading.</li></ul></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>10 Biggest Price Target Changes For Wednesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n10 Biggest Price Target Changes For Wednesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2022-02-02 20:28</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><ul><li>Keybanc lifted the price target for <b>Alphabet Inc.</b> from $3,090 to $3,400. Alphabet shares surged 11% to $3,055.00 in pre-market trading.</li><li>Wedbush cut the price target on <b>Starbucks Corporation</b> from $110 to $106. Starbucks shares fell 2.5% to $96.29 in pre-market trading.</li><li>Cowen &amp; Co. cut <b>Clover Health Investments, Corp.</b> price target from $7 to $3. Clover Health Investments shares rose 6.5% to $2.97 in pre-market trading.</li><li>UBS lowered <b>Zimmer Biomet Holdings, Inc.</b> price target from $172 to $130. Zimmer Biomet shares fell 0.2% to $123.80 in pre-market trading.</li><li>Citigroup cut <b>loanDepot, Inc.</b> price target from $12 to $5. loanDepot shares fell 4.9% to close at $4.46 on Tuesday.</li></ul><ul><li>Raymond James boosted the price target for <b>NXP Semiconductors N.V.</b> from $250 to $260. NXP Semiconductors shares rose 1.4% to $211.10 in pre-market trading.</li><li>SVB Leerink raised the price target on <b>Bio-Techne Corporation</b> from $530 to $575. Bio-Techne shares rose 0.1% to $401.76 in pre-market trading.</li><li>Goldman Sachs lowered <b>2U, Inc.</b> price target from $42 to $25. 2U shares rose 6.7% to $17.79 in pre-market trading.</li><li>UBS cut the price target on <b>Etsy, Inc.</b> from $215 to $180. Etsy shares rose 2% to $155.16 in pre-market trading.</li><li>Keybanc cut <b>PayPal Holdings, Inc.</b> price target from $250 to $200. PayPal shares fell 16% to $148.00 in pre-market trading.</li></ul></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PYPL":"PayPal","ZBH":"齐默巴奥米特控股","SBUX":"星巴克","TWOU":"2U Inc","CLOV":"Clover Health Corp","LDI":"loanDepot, Inc.","GOOGL":"谷歌A","ETSY":"Etsy, Inc.","TECH":"Techne Corporation","NXPI":"恩智浦"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1178657302","content_text":"Keybanc lifted the price target for Alphabet Inc. from $3,090 to $3,400. Alphabet shares surged 11% to $3,055.00 in pre-market trading.Wedbush cut the price target on Starbucks Corporation from $110 to $106. Starbucks shares fell 2.5% to $96.29 in pre-market trading.Cowen & Co. cut Clover Health Investments, Corp. price target from $7 to $3. Clover Health Investments shares rose 6.5% to $2.97 in pre-market trading.UBS lowered Zimmer Biomet Holdings, Inc. price target from $172 to $130. Zimmer Biomet shares fell 0.2% to $123.80 in pre-market trading.Citigroup cut loanDepot, Inc. price target from $12 to $5. loanDepot shares fell 4.9% to close at $4.46 on Tuesday.Raymond James boosted the price target for NXP Semiconductors N.V. from $250 to $260. NXP Semiconductors shares rose 1.4% to $211.10 in pre-market trading.SVB Leerink raised the price target on Bio-Techne Corporation from $530 to $575. Bio-Techne shares rose 0.1% to $401.76 in pre-market trading.Goldman Sachs lowered 2U, Inc. price target from $42 to $25. 2U shares rose 6.7% to $17.79 in pre-market trading.UBS cut the price target on Etsy, Inc. from $215 to $180. Etsy shares rose 2% to $155.16 in pre-market trading.Keybanc cut PayPal Holdings, Inc. price target from $250 to $200. PayPal shares fell 16% to $148.00 in pre-market trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":336,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9091660170,"gmtCreate":1643852941827,"gmtModify":1676533863751,"author":{"id":"3582933493509774","authorId":"3582933493509774","name":"linghui","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582933493509774","authorIdStr":"3582933493509774"},"themes":[],"htmlText":"Thanks","listText":"Thanks","text":"Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9091660170","repostId":"1196109622","repostType":4,"repost":{"id":"1196109622","kind":"news","pubTimestamp":1643852105,"share":"https://ttm.financial/m/news/1196109622?lang=&edition=fundamental","pubTime":"2022-02-03 09:35","market":"us","language":"en","title":"2 Biotech Stocks That Could Make You Richer","url":"https://stock-news.laohu8.com/highlight/detail?id=1196109622","media":"Motley Fool","summary":"Investing in the stock market won't make you rich overnight. But with a patient approach to investin","content":"<html><head></head><body><p>Investing in the stock market won&#39;t make you rich overnight. But with a patient approach to investing, coupled with several promising picks that could perform well in the long run, you can become much wealthier by investing in stocks over time.</p><p>Let&#39;s address the second part of this strategy: picking the right stocks, which isn&#39;t always an easy task. If you need some inspiration, here are two biotech stocks that are currently down and out with investors -- and while they carry some risk, I believe they have the potential to deliver strong returns to the patient shareholder: <a href=\"https://laohu8.com/S/BLUE\"><b>Bluebird Bio</b></a> and <a href=\"https://laohu8.com/S/EXEL\"><b>Exelixis</b></a>. Here&#39;s why.</p><p>1. <a href=\"https://laohu8.com/S/BLUE\"><b>Bluebird Bio</b></a></p><p>To say that Bluebird Bio has lagged the market in the past year would be an understatement. The gene-editing specialist has lost over 70% of its value in the trailing-12-month period, a horrible performance by any metric. The company owes this poor showing to a combination of factors, but as is usual with biotech companies, clinical and regulatory setbacks played a significant role.</p><p>On the positive side, Bluebird has proven that it can earn regulatory nods for multiple therapies -- few other gene-editing companies can say the same. Both Skysona, a treatment for a pediatric neurodegenerative disorder called cerebral adrenoleukodystrophy (CALD), and Zynteglo, a therapy for the blood disorder transfusion-dependent beta-thalassemia (TDT), were approved in Europe.</p><p>However, the company opted to leave the European market after failing to land a good deal with third-party payers for its approved gene-editing treatments. It also has had to pause a couple of clinical trials because of suspected adverse reactions. And it recently spun off its oncology business into a separate entity called<b>2Seventy Bio</b>.</p><p>Where does that leave Bluebird? It leaves the biotech with a pipeline focused on rare illnesses and some promising programs on the way. In September, the company submitted an application to the U.S. Food and Drug Administration for beti-cel, a treatment for TDT that was branded as Zynteglo in Europe.</p><p>There are few treatments for TDT. But Bluebird&#39;s version of the therapy that was approved in Europe costs a hefty 1.58 million euros. The biotech will almost certainly set a high price in the U.S. as well if beti-cel gets approved. There is no denying the value it would bring to patients: a one-time, curative treatment for a disorder that would otherwise require regular blood transfusions for survival.</p><p>The company has also submitted a U.S. application for eli-cel, a treatment for CALD that was approved in Europe this past December as Skysona. The FDA granted eli-cel priority review, which is reserved for therapies that could be an improvement over existing treatments. CALD is the most severe form of adrenoleukodystrophy (ALD).</p><p>ALD itself is pretty rare, and 40% of boys diagnosed with it end up developing CALD. The only known treatment for this illness is a stem-cell transplant. Eli-cel and beti-cel could both be approved this year with the potential to generate at least several hundred million dollars in peak annual sales -- if not significantly more.</p><p>Bluebird looks a bit on the risky side. It currently has no products on the market and is consistently unprofitable. And the biotech could run into even more regulatory headwinds, which would sink its stock even further.</p><p>However, Bluebird&#39;s current market cap is barely over $500 million. The market isn&#39;t putting much value in the company&#39;s programs at all. That&#39;s what makes this biotech a potentially attractive option. If the company&#39;s master plan actualizes, its shares could skyrocket.</p><p>2. <a href=\"https://laohu8.com/S/EXEL\"><b>Exelixis</b></a></p><p>Exelixis is best-known for its cancer medicine Cabometyx, approved for renal cell carcinoma (RCC) and hepatocellular carcinoma (HCC). In fact, it represents the bulk of the company&#39;s sales. But thebiotech&#39;s reliance on its crown jewel doesn&#39;t bode well for many investors, which partly explains why the company has lagged the market -- down some 18% over the past year.</p><p>Still, there is hope for Exelixis, which will report its full financial results on Feb. 17.</p><p>First, Cabometyx has continued to increase its sales while grinding out more indications. Exelixis recently announced preliminary results for last year. For the fourth quarter, it expects an 11.1% year-over-year increase in revenue to $300 million -- a solid performance. For the full year, it&#39;s estimating $1.08 billion in revenue, an increase of 9.4%. And for 2022, it&#39;s predicting $1.3 billion to $1.4 billion in revenue.</p><p>Cabometyx is also still being tested in dozens of clinical trials. Results from several phase 3 studies should come in this year, so the cancer medicine could once again earn label expansions. That&#39;s good news for Exelixis and its shareholders.</p><p>The biotech is now looking to replicate the success it&#39;s had with Cabometyx. It&#39;s advancing several pipeline candidates through early-stage clinical trials, including a trio of cancer therapies: XL092, XL102, and XB002. The company will update investors on the progress of these programs this year, and these updates could help send its stock price higher.</p><p>Within the next couple of years, these products should be moving into late-stage studies. Exelixis&#39; forward price-to-earnings ratio of about 15 -- while higher than the industry average of 11 -- is about as low as it has been in over two years. In the long run, Exelixis should rebound from its recent woes, and it might be worth adding shares of the company right now.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Biotech Stocks That Could Make You Richer</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Biotech Stocks That Could Make You Richer\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-03 09:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/02/02/2-biotech-stocks-that-could-make-you-richer/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Investing in the stock market won't make you rich overnight. But with a patient approach to investing, coupled with several promising picks that could perform well in the long run, you can become much...</p>\n\n<a href=\"https://www.fool.com/investing/2022/02/02/2-biotech-stocks-that-could-make-you-richer/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"EXEL":"伊克力西斯","BLUE":"bluebird bio Inc."},"source_url":"https://www.fool.com/investing/2022/02/02/2-biotech-stocks-that-could-make-you-richer/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1196109622","content_text":"Investing in the stock market won't make you rich overnight. But with a patient approach to investing, coupled with several promising picks that could perform well in the long run, you can become much wealthier by investing in stocks over time.Let's address the second part of this strategy: picking the right stocks, which isn't always an easy task. If you need some inspiration, here are two biotech stocks that are currently down and out with investors -- and while they carry some risk, I believe they have the potential to deliver strong returns to the patient shareholder: Bluebird Bio and Exelixis. Here's why.1. Bluebird BioTo say that Bluebird Bio has lagged the market in the past year would be an understatement. The gene-editing specialist has lost over 70% of its value in the trailing-12-month period, a horrible performance by any metric. The company owes this poor showing to a combination of factors, but as is usual with biotech companies, clinical and regulatory setbacks played a significant role.On the positive side, Bluebird has proven that it can earn regulatory nods for multiple therapies -- few other gene-editing companies can say the same. Both Skysona, a treatment for a pediatric neurodegenerative disorder called cerebral adrenoleukodystrophy (CALD), and Zynteglo, a therapy for the blood disorder transfusion-dependent beta-thalassemia (TDT), were approved in Europe.However, the company opted to leave the European market after failing to land a good deal with third-party payers for its approved gene-editing treatments. It also has had to pause a couple of clinical trials because of suspected adverse reactions. And it recently spun off its oncology business into a separate entity called2Seventy Bio.Where does that leave Bluebird? It leaves the biotech with a pipeline focused on rare illnesses and some promising programs on the way. In September, the company submitted an application to the U.S. Food and Drug Administration for beti-cel, a treatment for TDT that was branded as Zynteglo in Europe.There are few treatments for TDT. But Bluebird's version of the therapy that was approved in Europe costs a hefty 1.58 million euros. The biotech will almost certainly set a high price in the U.S. as well if beti-cel gets approved. There is no denying the value it would bring to patients: a one-time, curative treatment for a disorder that would otherwise require regular blood transfusions for survival.The company has also submitted a U.S. application for eli-cel, a treatment for CALD that was approved in Europe this past December as Skysona. The FDA granted eli-cel priority review, which is reserved for therapies that could be an improvement over existing treatments. CALD is the most severe form of adrenoleukodystrophy (ALD).ALD itself is pretty rare, and 40% of boys diagnosed with it end up developing CALD. The only known treatment for this illness is a stem-cell transplant. Eli-cel and beti-cel could both be approved this year with the potential to generate at least several hundred million dollars in peak annual sales -- if not significantly more.Bluebird looks a bit on the risky side. It currently has no products on the market and is consistently unprofitable. And the biotech could run into even more regulatory headwinds, which would sink its stock even further.However, Bluebird's current market cap is barely over $500 million. The market isn't putting much value in the company's programs at all. That's what makes this biotech a potentially attractive option. If the company's master plan actualizes, its shares could skyrocket.2. ExelixisExelixis is best-known for its cancer medicine Cabometyx, approved for renal cell carcinoma (RCC) and hepatocellular carcinoma (HCC). In fact, it represents the bulk of the company's sales. But thebiotech's reliance on its crown jewel doesn't bode well for many investors, which partly explains why the company has lagged the market -- down some 18% over the past year.Still, there is hope for Exelixis, which will report its full financial results on Feb. 17.First, Cabometyx has continued to increase its sales while grinding out more indications. Exelixis recently announced preliminary results for last year. For the fourth quarter, it expects an 11.1% year-over-year increase in revenue to $300 million -- a solid performance. For the full year, it's estimating $1.08 billion in revenue, an increase of 9.4%. And for 2022, it's predicting $1.3 billion to $1.4 billion in revenue.Cabometyx is also still being tested in dozens of clinical trials. Results from several phase 3 studies should come in this year, so the cancer medicine could once again earn label expansions. That's good news for Exelixis and its shareholders.The biotech is now looking to replicate the success it's had with Cabometyx. It's advancing several pipeline candidates through early-stage clinical trials, including a trio of cancer therapies: XL092, XL102, and XB002. The company will update investors on the progress of these programs this year, and these updates could help send its stock price higher.Within the next couple of years, these products should be moving into late-stage studies. Exelixis' forward price-to-earnings ratio of about 15 -- while higher than the industry average of 11 -- is about as low as it has been in over two years. In the long run, Exelixis should rebound from its recent woes, and it might be worth adding shares of the company right now.","news_type":1},"isVote":1,"tweetType":1,"viewCount":363,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9091972266,"gmtCreate":1643768850684,"gmtModify":1676533853939,"author":{"id":"3582933493509774","authorId":"3582933493509774","name":"linghui","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582933493509774","authorIdStr":"3582933493509774"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9091972266","repostId":"1100073306","repostType":4,"repost":{"id":"1100073306","kind":"news","pubTimestamp":1643762185,"share":"https://ttm.financial/m/news/1100073306?lang=&edition=fundamental","pubTime":"2022-02-02 08:36","market":"us","language":"en","title":"AT&T Is Getting Closer to a Clean Slate. Here’s What Comes Next","url":"https://stock-news.laohu8.com/highlight/detail?id=1100073306","media":"Barron's","summary":"After a saga of misguided M&A, there’s still work to be done for AT&T. Patrick T. Fallon/AFP via Get","content":"<html><head></head><body><p>After a saga of misguided M&amp;A, there’s still work to be done for AT&amp;T. Patrick T. Fallon/AFP via Getty Images</p><p>AT&amp;T shed some light on its pending exit from the media business on Tuesday, elaborating on the mechanics of this year’s mega-transaction to spin off WarnerMedia and merge it with Discovery. It’s one more step toward putting a saga of misguided M&amp;A behind it, but there’s still work to be done.</p><p>AT&amp;T (ticker: T) spent much of the past decade bulking up and dishing out billions of dollars on several acquisitions. The biggest were a $66 billion deal for DirecTV, which closed in July 2015, and the $106 billion acquisition of Time Warner, which closed in June 2018. That brought the 145-year-old phone business into new and more cyclical industries, and at one point made it the most-indebted company in the U.S.</p><p>Since the start of 2021 and under a new CEO, John Stankey, AT&amp;T has been slimming down. A spinoff of DirecTV and the company’s other pay-TV operations was announced and completed last year. Its Xandr advertising platform is being sold to Microsoft ( MSFT ). And the spinoff of WarnerMedia should close in the second quarter of this year, per management.</p><p>It will leave AT&amp;T with a telecom-only portfolio of businesses focused on 5G wireless and fiber-optic broadband. Those are high fixed-cost businesses, but also bring attractive economies of scale and recurring revenue from subscribers.</p><p>Shedding its conglomerate structure won’t make the challenges AT&amp;T faces in its telecom businesses go away, but it will allow management to focus time and resources on solving them. Competitive dynamics in both wired and wireless communications appear to be getting more intense, especially as industry subscriber growth slows following a pandemic-era boost. And AT&amp;T requires tens of billions of dollars in capital expenditures to improve its 5G and fiber networks.</p><p>AT&amp;T plans to expand its 5G C-band network to 200 million people in the U.S. by the end of 2023, and wants to reach 30 million homes and businesses with its fiber network by the end of 2025.</p><p>AT&amp;T will have more financial firepower to throw at those goals. Management expects $20 billion of annual free cash flow from the post-WarnerMedia telecom company, with 40% of that, or $8 billion, going toward its dividend. That compares with a $15 billion annual dividend commitment prior to the spinoff. The new payout will be some $1.11 per share annually, or a 6.3% yield at current prices (adjusting for the roughly $6.70 a share in Warner Bros. Discovery stock that AT&amp;T holders will receive). It matches the projections that AT&amp;T gave when announcing the transaction in May 2021.</p><p>AT&amp;T management expects to spend around $24 billion on capital investments in 2022. And the company will get an estimated $43 billion via the WarnerMedia transaction to put toward paying down debt. Management expects to get net debt to adjusted earnings before interest, taxes, depreciation, and amortization—or Ebitda—down to 2.5 times by the end of 2023. That compares with about 3.2 times today.</p><p>The result should be a leaner, meaner AT&amp;T that’s better equipped to face its challenges, but investors will want to see proof after feeling burned by years of management decisions that look poor in hindsight. Next up is a virtual investor day on March 11 focused on the post-WarnerMedia telecom business, which could include new long-term targets and plans.</p><p>The closing of the transaction itself should also bring some relief. Investors interested in Warner Bros. Discovery can shift to that stock, and those who want a yield-generating telecom stock can double down on AT&amp;T. Most of all, it will allow Wall Street to focus on AT&amp;T’s fundamentals and judge management on operations—and put an end to years of distracting and expensive M&amp;A sagas.</p></body></html>","source":"lsy1610680873436","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AT&T Is Getting Closer to a Clean Slate. Here’s What Comes Next</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAT&T Is Getting Closer to a Clean Slate. Here’s What Comes Next\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-02 08:36 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/att-media-spin-51643742609?mod=hp_LEAD_1><strong>Barron's</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After a saga of misguided M&A, there’s still work to be done for AT&T. Patrick T. Fallon/AFP via Getty ImagesAT&T shed some light on its pending exit from the media business on Tuesday, elaborating on...</p>\n\n<a href=\"https://www.barrons.com/articles/att-media-spin-51643742609?mod=hp_LEAD_1\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"T":"美国电话电报"},"source_url":"https://www.barrons.com/articles/att-media-spin-51643742609?mod=hp_LEAD_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1100073306","content_text":"After a saga of misguided M&A, there’s still work to be done for AT&T. Patrick T. Fallon/AFP via Getty ImagesAT&T shed some light on its pending exit from the media business on Tuesday, elaborating on the mechanics of this year’s mega-transaction to spin off WarnerMedia and merge it with Discovery. It’s one more step toward putting a saga of misguided M&A behind it, but there’s still work to be done.AT&T (ticker: T) spent much of the past decade bulking up and dishing out billions of dollars on several acquisitions. The biggest were a $66 billion deal for DirecTV, which closed in July 2015, and the $106 billion acquisition of Time Warner, which closed in June 2018. That brought the 145-year-old phone business into new and more cyclical industries, and at one point made it the most-indebted company in the U.S.Since the start of 2021 and under a new CEO, John Stankey, AT&T has been slimming down. A spinoff of DirecTV and the company’s other pay-TV operations was announced and completed last year. Its Xandr advertising platform is being sold to Microsoft ( MSFT ). And the spinoff of WarnerMedia should close in the second quarter of this year, per management.It will leave AT&T with a telecom-only portfolio of businesses focused on 5G wireless and fiber-optic broadband. Those are high fixed-cost businesses, but also bring attractive economies of scale and recurring revenue from subscribers.Shedding its conglomerate structure won’t make the challenges AT&T faces in its telecom businesses go away, but it will allow management to focus time and resources on solving them. Competitive dynamics in both wired and wireless communications appear to be getting more intense, especially as industry subscriber growth slows following a pandemic-era boost. And AT&T requires tens of billions of dollars in capital expenditures to improve its 5G and fiber networks.AT&T plans to expand its 5G C-band network to 200 million people in the U.S. by the end of 2023, and wants to reach 30 million homes and businesses with its fiber network by the end of 2025.AT&T will have more financial firepower to throw at those goals. Management expects $20 billion of annual free cash flow from the post-WarnerMedia telecom company, with 40% of that, or $8 billion, going toward its dividend. That compares with a $15 billion annual dividend commitment prior to the spinoff. The new payout will be some $1.11 per share annually, or a 6.3% yield at current prices (adjusting for the roughly $6.70 a share in Warner Bros. Discovery stock that AT&T holders will receive). It matches the projections that AT&T gave when announcing the transaction in May 2021.AT&T management expects to spend around $24 billion on capital investments in 2022. And the company will get an estimated $43 billion via the WarnerMedia transaction to put toward paying down debt. Management expects to get net debt to adjusted earnings before interest, taxes, depreciation, and amortization—or Ebitda—down to 2.5 times by the end of 2023. That compares with about 3.2 times today.The result should be a leaner, meaner AT&T that’s better equipped to face its challenges, but investors will want to see proof after feeling burned by years of management decisions that look poor in hindsight. Next up is a virtual investor day on March 11 focused on the post-WarnerMedia telecom business, which could include new long-term targets and plans.The closing of the transaction itself should also bring some relief. Investors interested in Warner Bros. Discovery can shift to that stock, and those who want a yield-generating telecom stock can double down on AT&T. Most of all, it will allow Wall Street to focus on AT&T’s fundamentals and judge management on operations—and put an end to years of distracting and expensive M&A sagas.","news_type":1},"isVote":1,"tweetType":1,"viewCount":628,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9091972866,"gmtCreate":1643768833295,"gmtModify":1676533853931,"author":{"id":"3582933493509774","authorId":"3582933493509774","name":"linghui","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582933493509774","authorIdStr":"3582933493509774"},"themes":[],"htmlText":"Ok&nbsp;","listText":"Ok&nbsp;","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9091972866","repostId":"2208351417","repostType":4,"repost":{"id":"2208351417","kind":"news","pubTimestamp":1643758197,"share":"https://ttm.financial/m/news/2208351417?lang=&edition=fundamental","pubTime":"2022-02-02 07:29","market":"us","language":"en","title":"Starbucks Shares Down 1% on Q4 EPS Miss; Revenues Better Than Expected","url":"https://stock-news.laohu8.com/highlight/detail?id=2208351417","media":"StreetInsider","summary":"Starbucks (NASDAQ: SBUX) shares were trading around 1% lower after-hours following the company’s Q1 ","content":"<html><head></head><body><p>Starbucks (NASDAQ: SBUX) shares were trading around 1% lower after-hours following the company’s Q1 results, with EPS of $0.72 missing the Street estimate of $0.79, while revenue growing 19% to $8.1 billion, beating the consensus of $7.97 billion.</p><p><img src=\"https://static.tigerbbs.com/43f905e68c4e641a8af42264a8c6ed63\" tg-width=\"921\" tg-height=\"730\" width=\"100%\" height=\"auto\"/></p><p>The revenue growth was primarily driven by a 13% growth in comparable store sales mainly from lapping the unfavorable impact of business disruption in 2020 due to the COVID-19 pandemic and strength of new U.S. company-operated stores compared to 2020 performance of stores closed as a part of the company’s North America Trade Area Transformation.</p><p>The company reported a global comparable store sales growth of 13%, driven by a 10% increase in comparable transactions and a 3% increase in average ticket. 484 net new stores were opened during the quarter, representing a 4% year-over-year unit growth, closing the year with a record 34,317 stores globally.</p></body></html>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Starbucks Shares Down 1% on Q4 EPS Miss; Revenues Better Than Expected</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStarbucks Shares Down 1% on Q4 EPS Miss; Revenues Better Than Expected\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-02 07:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19541534><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Starbucks (NASDAQ: SBUX) shares were trading around 1% lower after-hours following the company’s Q1 results, with EPS of $0.72 missing the Street estimate of $0.79, while revenue growing 19% to $8.1 ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19541534\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SBUX":"星巴克"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19541534","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2208351417","content_text":"Starbucks (NASDAQ: SBUX) shares were trading around 1% lower after-hours following the company’s Q1 results, with EPS of $0.72 missing the Street estimate of $0.79, while revenue growing 19% to $8.1 billion, beating the consensus of $7.97 billion.The revenue growth was primarily driven by a 13% growth in comparable store sales mainly from lapping the unfavorable impact of business disruption in 2020 due to the COVID-19 pandemic and strength of new U.S. company-operated stores compared to 2020 performance of stores closed as a part of the company’s North America Trade Area Transformation.The company reported a global comparable store sales growth of 13%, driven by a 10% increase in comparable transactions and a 3% increase in average ticket. 484 net new stores were opened during the quarter, representing a 4% year-over-year unit growth, closing the year with a record 34,317 stores globally.","news_type":1},"isVote":1,"tweetType":1,"viewCount":495,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9091976377,"gmtCreate":1643768778805,"gmtModify":1676533853907,"author":{"id":"3582933493509774","authorId":"3582933493509774","name":"linghui","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582933493509774","authorIdStr":"3582933493509774"},"themes":[],"htmlText":"Gd info","listText":"Gd info","text":"Gd info","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9091976377","repostId":"1181481003","repostType":4,"repost":{"id":"1181481003","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1643722728,"share":"https://ttm.financial/m/news/1181481003?lang=&edition=fundamental","pubTime":"2022-02-01 21:38","market":"us","language":"en","title":"MicroStrategy shares rose 7% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1181481003","media":"Tiger Newspress","summary":"MicroStrategy shares rose 7% in premarket trading.As of Jan. 31, the company held about 125,051 bitc","content":"<html><head></head><body><p>MicroStrategy shares rose 7% in premarket trading.<img src=\"https://static.tigerbbs.com/9682bd3ba54feb42c63bc9be06e419fa\" tg-width=\"699\" tg-height=\"598\" width=\"100%\" height=\"auto\"/></p><p>As of Jan. 31, the company held about 125,051 bitcoins purchased at an average price of $30,200.</p><p>MicroStrategy (Nasdaq: MSTR), the business-intelligence software company that’s taken to accumulating bitcoin, said it bought approximately 660 bitcoins for around $25 million between Dec. 30, 2021 and Jan. 31, 2022.</p><p>The company paid an average price of $37,865 per bitcoin, it said in a statement.</p><p>Tysons Corner, Virginia-based MicroStrategy now holds a total of 125,051 bitcoins, valued at about $4.8 billion at the current bitcoin price of $38,700.</p><p>Shares of MicroStrategy have fallen around 34% over the last month.</p><p>CEO Michael Saylor has been insistent that the company has no plans to sell its bitcoin holdings and is in for the long-term.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MicroStrategy shares rose 7% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMicroStrategy shares rose 7% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-02-01 21:38</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>MicroStrategy shares rose 7% in premarket trading.<img src=\"https://static.tigerbbs.com/9682bd3ba54feb42c63bc9be06e419fa\" tg-width=\"699\" tg-height=\"598\" width=\"100%\" height=\"auto\"/></p><p>As of Jan. 31, the company held about 125,051 bitcoins purchased at an average price of $30,200.</p><p>MicroStrategy (Nasdaq: MSTR), the business-intelligence software company that’s taken to accumulating bitcoin, said it bought approximately 660 bitcoins for around $25 million between Dec. 30, 2021 and Jan. 31, 2022.</p><p>The company paid an average price of $37,865 per bitcoin, it said in a statement.</p><p>Tysons Corner, Virginia-based MicroStrategy now holds a total of 125,051 bitcoins, valued at about $4.8 billion at the current bitcoin price of $38,700.</p><p>Shares of MicroStrategy have fallen around 34% over the last month.</p><p>CEO Michael Saylor has been insistent that the company has no plans to sell its bitcoin holdings and is in for the long-term.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MSTR":"MicroStrategy"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1181481003","content_text":"MicroStrategy shares rose 7% in premarket trading.As of Jan. 31, the company held about 125,051 bitcoins purchased at an average price of $30,200.MicroStrategy (Nasdaq: MSTR), the business-intelligence software company that’s taken to accumulating bitcoin, said it bought approximately 660 bitcoins for around $25 million between Dec. 30, 2021 and Jan. 31, 2022.The company paid an average price of $37,865 per bitcoin, it said in a statement.Tysons Corner, Virginia-based MicroStrategy now holds a total of 125,051 bitcoins, valued at about $4.8 billion at the current bitcoin price of $38,700.Shares of MicroStrategy have fallen around 34% over the last month.CEO Michael Saylor has been insistent that the company has no plans to sell its bitcoin holdings and is in for the long-term.","news_type":1},"isVote":1,"tweetType":1,"viewCount":399,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9091978587,"gmtCreate":1643768729351,"gmtModify":1676533853898,"author":{"id":"3582933493509774","authorId":"3582933493509774","name":"linghui","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582933493509774","authorIdStr":"3582933493509774"},"themes":[],"htmlText":"Above ok!","listText":"Above ok!","text":"Above ok!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9091978587","repostId":"2208633473","repostType":4,"repost":{"id":"2208633473","kind":"highlight","pubTimestamp":1643721720,"share":"https://ttm.financial/m/news/2208633473?lang=&edition=fundamental","pubTime":"2022-02-01 21:22","market":"us","language":"en","title":"5 High-Yield Dividend Stocks That Can Save Your Portfolio During a Stock Market Crash","url":"https://stock-news.laohu8.com/highlight/detail?id=2208633473","media":"Motley Fool","summary":"These income stocks, with yields ranging from 4.1% to 11.3%, can be your rock during periods of heightened volatility.","content":"<html><head></head><body><p>January provided a not-so-subtle reminder that stock market crashes and corrections are a normal part of the investing cycle, and they can occur without warning. Both the benchmark <b>S&amp;P 500</b> and growth stock-driven <b>Nasdaq Composite</b> endured their steepest corrections in close to two years.</p><p>While steep moves lower in the market in a short time frame can be unnerving, arguably <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the smartest ways to save your portfolio from these periods of heightened volatility is to buy high-yield dividend stocks (i.e., those with yields of 4% or above).</p><p>Dividend stocks offer a number of advantages to investors. For instance, companies that pay a dividend are often profitable on a recurring basis and time-tested. Additionally, income stocks have a rich history of handily outperforming their non-dividend-paying peers.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/19e231762b394073ae50eae89896fa40\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"/><span>Image source: Getty Images.</span></p><p>If this recent sell-off does turn into a full-blown stock market crash, the following high-yield dividend stocks can be your saviors.</p><h2>AT&amp;T: 8.3% yield</h2><p>If you crave stability, telecom stocks like <b>AT&amp;T</b> (NYSE:T) are a good place to find it. AT&amp;T has two key catalysts that can deliver modest organic growth over the next half decade, all while the company parses out an above-average payout.</p><p>For starters, ongoing upgrades to 5G wireless infrastructure are going to be a big deal. Even though the investments AT&amp;T is making in wireless infrastructure are sizable, consumers and businesses have been waiting a decade for an upgrade to wireless download speeds. The rollout of 5G speeds in the U.S. should encourage businesses and consumers to replace their devices over the coming years. Since data is what drives AT&amp;T&#39;s juicy wireless margins, faster download speeds can increase the wireless segment growth rate.</p><p>The other growth catalyst for AT&amp;T is the expected spinoff of content arm WarnerMedia, which will be merged with <b>Discovery</b>. This new media entity will offer a larger content library with over 85 million pro forma subscribers, and should result in at least $3 billion in annual cost synergies. Most importantly, AT&amp;T will be able to modestly reduce its dividend following the spinoff and focus on debt reduction. Even after this dividend cut, AT&amp;T should still offer a hearty yield of around 5%.</p><p><img src=\"https://static.tigerbbs.com/ab366a5444f328185236645a8d066233\" tg-width=\"700\" tg-height=\"465\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/></p><h2>Enterprise Products Partners: 7.9% yield</h2><p>With the economic chaos caused by the pandemic still fresh in many investors&#39; minds, the idea of an oil stock providing &#34;safety&#34; to a portfolio during a crash might be laughable. But most oil and gas companies can&#39;t hold a candle to <b>Enterprise Products Partners</b> (NYSE:EPD) and its nearly 8% yield.</p><p>When crude oil demand experienced a historic drawdown in 2020, most upstream companies (drillers and explorers) were slammed. Enterprise Products Partners is a midstream company. It owns around 50,000 miles of oil and gas transmission pipeline, 19 natural gas processing facilities, and has approximately 14 billion cubic feet of natural gas storage space.</p><p>The beauty of this operating model can be seen in the way the company structures its contracts with drillers. With volume and price commitments in place well in advance, Enterprise Products Partners has a good bead on how much cash flow it&#39;ll be generating looking out multiple quarters. This cash flow predictability is the key to undertaking new infrastructure projects without compromising its profitability or 23-year streak of increasing its base annual payout.</p><p>It&#39;s also worth noting that at no point during the crash in crude oil prices in 2020 was Enterprise Products Partners&#39; dividend in danger of being cut.</p><p><img src=\"https://static.tigerbbs.com/b7c96011fb6b25a1831f75e74ea29790\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/></p><h2>Philip Morris International: 4.8% yield</h2><p>Another high-yield dividend stock that can save your portfolio during a stock market crash is global tobacco giant <b>Philip Morris International</b> (NYSE:PM). Philip Morris sports a yield of nearly 5%, with management intent on paying out a significant portion of annual profits as a dividend.</p><p>Three factors are responsible for making this company such a rock-solid investment in virtually any economic environment. First off, tobacco contains nicotine, which is an addictive chemical. These addictive properties allow the company to pass along price increases that help it outpace any volume declines it might be contending with in developed markets.</p><p>Second, Philip Morris&#39; geographic diversity is playing a big role. This is a company that&#39;s operating in more than 180 countries worldwide. If regulations are tightening in one market, chances are a burgeoning middle class looking for simple luxuries, like tobacco products, are making up the difference in an emerging market.</p><p>And third, Philip Morris is looking beyond its traditional tobacco lineup with its IQOS heated tobacco system. Through the first nine months of 2021, it held a close to 7% share of the heated tobacco market in countries where IQOS is sold (excluding the U.S.).</p><p><img src=\"https://static.tigerbbs.com/4a7ee02d220d347caebe42156ebb3644\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/></p><h2><a href=\"https://laohu8.com/S/NLY\">Annaly Capital Management</a>: 11.3% yield</h2><p>Among ultra-high-yield stocks, few can provide more stability to your portfolio during a stock market crash than mortgage real estate investment trust (REIT) <b>Annaly Capital Management</b> (NYSE:NLY). Annaly has paid out north of $20 billion in dividends over the past quarter of a century and has averaged a yield of around 10% for the past two decades.</p><p>Mortgage REITs like Annaly are attempting to borrow money at low, short-term lending rates, then using this capital to purchase higher-yielding long-term assets, like mortgage-backed securities. The difference between the yield the company receives and its average borrowing rate is known as &#34;net interest margin.&#34; The larger the net interest margin (NIM), the more profitable Annaly can be.</p><p>The good news here is Annaly has hit the sweet spot of its growth cycle. During the early stage of economic recoveries, it&#39;s not uncommon for the yield curve to steepen. When this difference in yield between short-and-long-term Treasury bonds widens, the company&#39;s NIM tends to rise.</p><p>What&#39;s more, over 90% of Annaly&#39;s asset portfolio is agency securities. These are assets backed by the federal government in the event of default. This added protection is what allows the company to deploy leverage to maximize profits and maintain its double-digit yield.</p><p><img src=\"https://static.tigerbbs.com/b18b49b2b35da2fc49e0a83b883d1c22\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/></p><h2>AbbVie: 4.1% yield</h2><p>A fifth high-yield dividend stock that can save your portfolio if a market crash strikes is pharmaceutical stock <b>AbbVie</b> (NYSE:ABBV). Although AbbVie&#39;s 4% yield pales in comparison to the likes of Annaly, bear in mind that the former&#39;s share price has more than doubled over the past 2.5 years.</p><p>There&#39;s little question that anti-inflammatory drug Humira is the superstar of AbbVie&#39;s product portfolio. Through the first nine months of 2021, Humira brought in $15.4 billion of the company&#39;s $41.2 billion in net product sales.  If not for the COVID-19 vaccines, Humira would be the world&#39;s top-selling drug. Despite facing biosimilar competition in Europe, Humira can remain AbbVie&#39;s cash cow for years to come.</p><p>On top of organic innovation, AbbVie hasn&#39;t been afraid to turn to acquisitions to diversify its revenue stream and boost its long-term growth potential. In May 2020, the company made a splash with its cash-and-stock deal to acquire Allergan. This deal added new lines of revenue (e.g., aesthetics and eye care), as well as a brand-name blockbuster in Botox.</p><p>Since people don&#39;t get to choose when they get sick or what ailment(s) they develop, demand for pharmaceuticals tends to remain steady in any economic environment. That makes healthcare stocks like AbbVie a solid bet to outperform during a market crash.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 High-Yield Dividend Stocks That Can Save Your Portfolio During a Stock Market Crash</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 High-Yield Dividend Stocks That Can Save Your Portfolio During a Stock Market Crash\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-01 21:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/02/01/5-high-yield-dividend-stocks-save-portfolio-crash/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>January provided a not-so-subtle reminder that stock market crashes and corrections are a normal part of the investing cycle, and they can occur without warning. Both the benchmark S&P 500 and growth ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/02/01/5-high-yield-dividend-stocks-save-portfolio-crash/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ABBV":"艾伯维公司","NIM":"纽文精选市政基金","BK4515":"5G概念","BK4144":"石油与天然气的储存和运输","BK4507":"流媒体概念","BK4534":"瑞士信贷持仓","BK4139":"生物科技","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4075":"烟草","BK4566":"资本集团","NLY":"Annaly Capital Management","BK4559":"巴菲特持仓","BK4550":"红杉资本持仓","EPD":"Enterprise Products Partners L.P","BK4115":"综合电信业务","REIT":"ALPS Active REIT ETF","BK4561":"索罗斯持仓","BK4110":"抵押房地产投资信托","T":"美国电话电报","PM":"菲利普莫里斯"},"source_url":"https://www.fool.com/investing/2022/02/01/5-high-yield-dividend-stocks-save-portfolio-crash/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2208633473","content_text":"January provided a not-so-subtle reminder that stock market crashes and corrections are a normal part of the investing cycle, and they can occur without warning. Both the benchmark S&P 500 and growth stock-driven Nasdaq Composite endured their steepest corrections in close to two years.While steep moves lower in the market in a short time frame can be unnerving, arguably one of the smartest ways to save your portfolio from these periods of heightened volatility is to buy high-yield dividend stocks (i.e., those with yields of 4% or above).Dividend stocks offer a number of advantages to investors. For instance, companies that pay a dividend are often profitable on a recurring basis and time-tested. Additionally, income stocks have a rich history of handily outperforming their non-dividend-paying peers.Image source: Getty Images.If this recent sell-off does turn into a full-blown stock market crash, the following high-yield dividend stocks can be your saviors.AT&T: 8.3% yieldIf you crave stability, telecom stocks like AT&T (NYSE:T) are a good place to find it. AT&T has two key catalysts that can deliver modest organic growth over the next half decade, all while the company parses out an above-average payout.For starters, ongoing upgrades to 5G wireless infrastructure are going to be a big deal. Even though the investments AT&T is making in wireless infrastructure are sizable, consumers and businesses have been waiting a decade for an upgrade to wireless download speeds. The rollout of 5G speeds in the U.S. should encourage businesses and consumers to replace their devices over the coming years. Since data is what drives AT&T's juicy wireless margins, faster download speeds can increase the wireless segment growth rate.The other growth catalyst for AT&T is the expected spinoff of content arm WarnerMedia, which will be merged with Discovery. This new media entity will offer a larger content library with over 85 million pro forma subscribers, and should result in at least $3 billion in annual cost synergies. Most importantly, AT&T will be able to modestly reduce its dividend following the spinoff and focus on debt reduction. Even after this dividend cut, AT&T should still offer a hearty yield of around 5%.Enterprise Products Partners: 7.9% yieldWith the economic chaos caused by the pandemic still fresh in many investors' minds, the idea of an oil stock providing \"safety\" to a portfolio during a crash might be laughable. But most oil and gas companies can't hold a candle to Enterprise Products Partners (NYSE:EPD) and its nearly 8% yield.When crude oil demand experienced a historic drawdown in 2020, most upstream companies (drillers and explorers) were slammed. Enterprise Products Partners is a midstream company. It owns around 50,000 miles of oil and gas transmission pipeline, 19 natural gas processing facilities, and has approximately 14 billion cubic feet of natural gas storage space.The beauty of this operating model can be seen in the way the company structures its contracts with drillers. With volume and price commitments in place well in advance, Enterprise Products Partners has a good bead on how much cash flow it'll be generating looking out multiple quarters. This cash flow predictability is the key to undertaking new infrastructure projects without compromising its profitability or 23-year streak of increasing its base annual payout.It's also worth noting that at no point during the crash in crude oil prices in 2020 was Enterprise Products Partners' dividend in danger of being cut.Philip Morris International: 4.8% yieldAnother high-yield dividend stock that can save your portfolio during a stock market crash is global tobacco giant Philip Morris International (NYSE:PM). Philip Morris sports a yield of nearly 5%, with management intent on paying out a significant portion of annual profits as a dividend.Three factors are responsible for making this company such a rock-solid investment in virtually any economic environment. First off, tobacco contains nicotine, which is an addictive chemical. These addictive properties allow the company to pass along price increases that help it outpace any volume declines it might be contending with in developed markets.Second, Philip Morris' geographic diversity is playing a big role. This is a company that's operating in more than 180 countries worldwide. If regulations are tightening in one market, chances are a burgeoning middle class looking for simple luxuries, like tobacco products, are making up the difference in an emerging market.And third, Philip Morris is looking beyond its traditional tobacco lineup with its IQOS heated tobacco system. Through the first nine months of 2021, it held a close to 7% share of the heated tobacco market in countries where IQOS is sold (excluding the U.S.).Annaly Capital Management: 11.3% yieldAmong ultra-high-yield stocks, few can provide more stability to your portfolio during a stock market crash than mortgage real estate investment trust (REIT) Annaly Capital Management (NYSE:NLY). Annaly has paid out north of $20 billion in dividends over the past quarter of a century and has averaged a yield of around 10% for the past two decades.Mortgage REITs like Annaly are attempting to borrow money at low, short-term lending rates, then using this capital to purchase higher-yielding long-term assets, like mortgage-backed securities. The difference between the yield the company receives and its average borrowing rate is known as \"net interest margin.\" The larger the net interest margin (NIM), the more profitable Annaly can be.The good news here is Annaly has hit the sweet spot of its growth cycle. During the early stage of economic recoveries, it's not uncommon for the yield curve to steepen. When this difference in yield between short-and-long-term Treasury bonds widens, the company's NIM tends to rise.What's more, over 90% of Annaly's asset portfolio is agency securities. These are assets backed by the federal government in the event of default. This added protection is what allows the company to deploy leverage to maximize profits and maintain its double-digit yield.AbbVie: 4.1% yieldA fifth high-yield dividend stock that can save your portfolio if a market crash strikes is pharmaceutical stock AbbVie (NYSE:ABBV). Although AbbVie's 4% yield pales in comparison to the likes of Annaly, bear in mind that the former's share price has more than doubled over the past 2.5 years.There's little question that anti-inflammatory drug Humira is the superstar of AbbVie's product portfolio. Through the first nine months of 2021, Humira brought in $15.4 billion of the company's $41.2 billion in net product sales.  If not for the COVID-19 vaccines, Humira would be the world's top-selling drug. Despite facing biosimilar competition in Europe, Humira can remain AbbVie's cash cow for years to come.On top of organic innovation, AbbVie hasn't been afraid to turn to acquisitions to diversify its revenue stream and boost its long-term growth potential. In May 2020, the company made a splash with its cash-and-stock deal to acquire Allergan. This deal added new lines of revenue (e.g., aesthetics and eye care), as well as a brand-name blockbuster in Botox.Since people don't get to choose when they get sick or what ailment(s) they develop, demand for pharmaceuticals tends to remain steady in any economic environment. That makes healthcare stocks like AbbVie a solid bet to outperform during a market crash.","news_type":1},"isVote":1,"tweetType":1,"viewCount":578,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9091973784,"gmtCreate":1643768538374,"gmtModify":1676533853851,"author":{"id":"3582933493509774","authorId":"3582933493509774","name":"linghui","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582933493509774","authorIdStr":"3582933493509774"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9091973784","repostId":"2208359771","repostType":4,"repost":{"id":"2208359771","kind":"news","pubTimestamp":1643759992,"share":"https://ttm.financial/m/news/2208359771?lang=&edition=fundamental","pubTime":"2022-02-02 07:59","market":"us","language":"en","title":"Wall St Posts Gains after Choppy Session, Energy Index Hits New Peak","url":"https://stock-news.laohu8.com/highlight/detail?id=2208359771","media":"Reuters","summary":"* Exxon Mobil gains on strong results* UPS jumps on upbeat forecast* AT&T down on halving dividend* ","content":"<html><head></head><body><p>* Exxon Mobil gains on strong results</p><p>* UPS jumps on upbeat forecast</p><p>* AT&amp;T down on halving dividend</p><p>* Indexes rise: Dow 0.78%, S&amp;P 0.69%, Nasdaq 0.75%</p><p>All three Wall Street benchmarks advanced on Tuesday and the energy index closed at a record high, although seesaw trading reflected investor uncertainty about how to play the current market.</p><p>Recent sessions have been choppy, as the prospect of an aggressive rate-hike campaign by the U.S. Federal Reserve looms large and investors seek to position themselves accordingly - a task not made easy by lingering pandemic influences on the economy and geopolitical tension in Europe.</p><p>But despite losing 5.3% and 3.3% in January respectively, the S&amp;P 500 and the Dow have now recorded three straight days of gains, with the Nasdaq - which dropped 8.99% in the first month of 2022 - posting four positive sessions in the last five.</p><p>It did not look like that would happen earlier in the session, when all three benchmarks traded lower in the wake of data from the Labor Department and the ISM&#39;s purchasing managers&#39; index (PMI).</p><p>&#34;You&#39;re starting to see that there are a lot of investors who are concerned about valuations going forward, but there are others who are worried about growth, so it seems the wall of worry keeps on growing as the economy exits this pandemic,&#34; said Ed Moya, senior market analyst at OANDA.</p><p>Philadelphia Fed President Patrick Harker said on Tuesday it may be appropriate for the U.S. central bank to raise rates four times this year, while Atlanta Fed president Raphael Bostic said the Fed needs to act &#34;soon&#34; to control inflation expectations.</p><p>Traders are betting on five rate hikes this year, with some Wall Street analysts expecting seven hikes.</p><p>&#34;This will be the year when Fed will pull back support ... the markets will not be on steroids anymore and may go through a phase of detox,&#34; said Anu Gaggar, global investment strategist at Commonwealth Financial Network.</p><p>Geopolitical tensions added to market volatility, with Ukraine&#39;s president signing a decree to boost his armed forces by 100,000 troops over three years, as European leaders lined up to back him in a standoff with Russia and the United States demanded immediate Russian de-escalation.</p><p>The Dow Jones Industrial Average rose 273.38 points, or 0.78%, to 35,405.24, the S&amp;P 500 gained 30.99 points, or 0.69%, to 4,546.54 and the Nasdaq Composite added 106.12 points, or 0.75%, to 14,346.00.</p><p>Once again, energy led the major S&amp;P sectors, gaining 3.5% to close at a record high. The index is, by far, the best performer in 2022, up 23.2%, as U.S. crude hovers near a seven-year high.</p><p>Those strong energy prices helped Exxon Mobil Corp to post its biggest quarterly profit in seven years on Tuesday. Its stock jumped 6.4% as a result, to close above the $80-per-share mark for the first time since April 2019.</p><p>As of Tuesday, 184 S&amp;P 500 companies posted quarterly results, of which 78.8% reported earnings above analyst expectations, according to Refinitiv.</p><p>Google parent Alphabet Inc rose 1.7% ahead of quarterly results published after the bell. Amazon Inc and <a href=\"https://laohu8.com/S/FB\">Meta Platforms</a> Inc are also on deck later this week.</p><p>Of those which reported earlier on Tuesday, United Parcel Service Inc jumped 14.1% - its biggest <a href=\"https://laohu8.com/S/AONE.U\">one</a>-day gain in 18 months - after projecting 2022 revenue above market expectations.</p><p>AT&amp;T Inc dropped 4.2% after saying it will spin off WarnerMedia in a $43 billion transaction to merge its media properties with Discovery Inc and also cut its dividend by nearly half.</p><p>Volume on U.S. exchanges was 11.71 billion shares, compared with the 12.45 billion average for the full session over the last 20 trading days.</p><p>The S&amp;P 500 posted 18 new 52-week highs and one new low; the Nasdaq Composite recorded 43 new highs and 18 new lows.</p></body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall St Posts Gains after Choppy Session, Energy Index Hits New Peak</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall St Posts Gains after Choppy Session, Energy Index Hits New Peak\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-02 07:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/us-stocks-wall-st-posts-213756846.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>* Exxon Mobil gains on strong results* UPS jumps on upbeat forecast* AT&T down on halving dividend* Indexes rise: Dow 0.78%, S&P 0.69%, Nasdaq 0.75%All three Wall Street benchmarks advanced on Tuesday...</p>\n\n<a href=\"https://finance.yahoo.com/news/us-stocks-wall-st-posts-213756846.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4201":"综合性石油与天然气企业","BK4023":"应用软件","BK4516":"特朗普概念","BK4554":"元宇宙及AR概念","BK4532":"文艺复兴科技持仓","CGEM":"Cullinan Therapeutics","SANA":"Sana Biotechnology, Inc.","XOM":"埃克森美孚","BK4553":"喜马拉雅资本持仓","GOOGL":"谷歌A","LHDX":"Lucira Health, Inc.","BK4507":"流媒体概念","BK4534":"瑞士信贷持仓","GOOG":"谷歌","ONTF":"ON24, Inc.","BK4139":"生物科技","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4566":"资本集团","BK4007":"制药","APR":"Apria, Inc.","BK4525":"远程办公概念","BK4196":"保健护理服务","SPY":"标普500ETF","BK4082":"医疗保健设备","BK4559":"巴菲特持仓","BK4538":"云计算","BK4077":"互动媒体与服务","BK4527":"明星科技股","BK4550":"红杉资本持仓",".SPX":"S&P 500 Index","BK4503":"景林资产持仓","BK4561":"索罗斯持仓","T":"美国电话电报","BK4504":"桥水持仓","COMP":"Compass, Inc.","LABP":"Landos Biopharma, Inc.","BK4548":"巴美列捷福持仓","BK4514":"搜索引擎"},"source_url":"https://finance.yahoo.com/news/us-stocks-wall-st-posts-213756846.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2208359771","content_text":"* Exxon Mobil gains on strong results* UPS jumps on upbeat forecast* AT&T down on halving dividend* Indexes rise: Dow 0.78%, S&P 0.69%, Nasdaq 0.75%All three Wall Street benchmarks advanced on Tuesday and the energy index closed at a record high, although seesaw trading reflected investor uncertainty about how to play the current market.Recent sessions have been choppy, as the prospect of an aggressive rate-hike campaign by the U.S. Federal Reserve looms large and investors seek to position themselves accordingly - a task not made easy by lingering pandemic influences on the economy and geopolitical tension in Europe.But despite losing 5.3% and 3.3% in January respectively, the S&P 500 and the Dow have now recorded three straight days of gains, with the Nasdaq - which dropped 8.99% in the first month of 2022 - posting four positive sessions in the last five.It did not look like that would happen earlier in the session, when all three benchmarks traded lower in the wake of data from the Labor Department and the ISM's purchasing managers' index (PMI).\"You're starting to see that there are a lot of investors who are concerned about valuations going forward, but there are others who are worried about growth, so it seems the wall of worry keeps on growing as the economy exits this pandemic,\" said Ed Moya, senior market analyst at OANDA.Philadelphia Fed President Patrick Harker said on Tuesday it may be appropriate for the U.S. central bank to raise rates four times this year, while Atlanta Fed president Raphael Bostic said the Fed needs to act \"soon\" to control inflation expectations.Traders are betting on five rate hikes this year, with some Wall Street analysts expecting seven hikes.\"This will be the year when Fed will pull back support ... the markets will not be on steroids anymore and may go through a phase of detox,\" said Anu Gaggar, global investment strategist at Commonwealth Financial Network.Geopolitical tensions added to market volatility, with Ukraine's president signing a decree to boost his armed forces by 100,000 troops over three years, as European leaders lined up to back him in a standoff with Russia and the United States demanded immediate Russian de-escalation.The Dow Jones Industrial Average rose 273.38 points, or 0.78%, to 35,405.24, the S&P 500 gained 30.99 points, or 0.69%, to 4,546.54 and the Nasdaq Composite added 106.12 points, or 0.75%, to 14,346.00.Once again, energy led the major S&P sectors, gaining 3.5% to close at a record high. The index is, by far, the best performer in 2022, up 23.2%, as U.S. crude hovers near a seven-year high.Those strong energy prices helped Exxon Mobil Corp to post its biggest quarterly profit in seven years on Tuesday. Its stock jumped 6.4% as a result, to close above the $80-per-share mark for the first time since April 2019.As of Tuesday, 184 S&P 500 companies posted quarterly results, of which 78.8% reported earnings above analyst expectations, according to Refinitiv.Google parent Alphabet Inc rose 1.7% ahead of quarterly results published after the bell. Amazon Inc and Meta Platforms Inc are also on deck later this week.Of those which reported earlier on Tuesday, United Parcel Service Inc jumped 14.1% - its biggest one-day gain in 18 months - after projecting 2022 revenue above market expectations.AT&T Inc dropped 4.2% after saying it will spin off WarnerMedia in a $43 billion transaction to merge its media properties with Discovery Inc and also cut its dividend by nearly half.Volume on U.S. exchanges was 11.71 billion shares, compared with the 12.45 billion average for the full session over the last 20 trading days.The S&P 500 posted 18 new 52-week highs and one new low; the Nasdaq Composite recorded 43 new highs and 18 new lows.","news_type":1},"isVote":1,"tweetType":1,"viewCount":231,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":9091972266,"gmtCreate":1643768850684,"gmtModify":1676533853939,"author":{"id":"3582933493509774","authorId":"3582933493509774","name":"linghui","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582933493509774","authorIdStr":"3582933493509774"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9091972266","repostId":"1100073306","repostType":4,"repost":{"id":"1100073306","kind":"news","pubTimestamp":1643762185,"share":"https://ttm.financial/m/news/1100073306?lang=&edition=fundamental","pubTime":"2022-02-02 08:36","market":"us","language":"en","title":"AT&T Is Getting Closer to a Clean Slate. Here’s What Comes Next","url":"https://stock-news.laohu8.com/highlight/detail?id=1100073306","media":"Barron's","summary":"After a saga of misguided M&A, there’s still work to be done for AT&T. Patrick T. Fallon/AFP via Get","content":"<html><head></head><body><p>After a saga of misguided M&amp;A, there’s still work to be done for AT&amp;T. Patrick T. Fallon/AFP via Getty Images</p><p>AT&amp;T shed some light on its pending exit from the media business on Tuesday, elaborating on the mechanics of this year’s mega-transaction to spin off WarnerMedia and merge it with Discovery. It’s one more step toward putting a saga of misguided M&amp;A behind it, but there’s still work to be done.</p><p>AT&amp;T (ticker: T) spent much of the past decade bulking up and dishing out billions of dollars on several acquisitions. The biggest were a $66 billion deal for DirecTV, which closed in July 2015, and the $106 billion acquisition of Time Warner, which closed in June 2018. That brought the 145-year-old phone business into new and more cyclical industries, and at one point made it the most-indebted company in the U.S.</p><p>Since the start of 2021 and under a new CEO, John Stankey, AT&amp;T has been slimming down. A spinoff of DirecTV and the company’s other pay-TV operations was announced and completed last year. Its Xandr advertising platform is being sold to Microsoft ( MSFT ). And the spinoff of WarnerMedia should close in the second quarter of this year, per management.</p><p>It will leave AT&amp;T with a telecom-only portfolio of businesses focused on 5G wireless and fiber-optic broadband. Those are high fixed-cost businesses, but also bring attractive economies of scale and recurring revenue from subscribers.</p><p>Shedding its conglomerate structure won’t make the challenges AT&amp;T faces in its telecom businesses go away, but it will allow management to focus time and resources on solving them. Competitive dynamics in both wired and wireless communications appear to be getting more intense, especially as industry subscriber growth slows following a pandemic-era boost. And AT&amp;T requires tens of billions of dollars in capital expenditures to improve its 5G and fiber networks.</p><p>AT&amp;T plans to expand its 5G C-band network to 200 million people in the U.S. by the end of 2023, and wants to reach 30 million homes and businesses with its fiber network by the end of 2025.</p><p>AT&amp;T will have more financial firepower to throw at those goals. Management expects $20 billion of annual free cash flow from the post-WarnerMedia telecom company, with 40% of that, or $8 billion, going toward its dividend. That compares with a $15 billion annual dividend commitment prior to the spinoff. The new payout will be some $1.11 per share annually, or a 6.3% yield at current prices (adjusting for the roughly $6.70 a share in Warner Bros. Discovery stock that AT&amp;T holders will receive). It matches the projections that AT&amp;T gave when announcing the transaction in May 2021.</p><p>AT&amp;T management expects to spend around $24 billion on capital investments in 2022. And the company will get an estimated $43 billion via the WarnerMedia transaction to put toward paying down debt. Management expects to get net debt to adjusted earnings before interest, taxes, depreciation, and amortization—or Ebitda—down to 2.5 times by the end of 2023. That compares with about 3.2 times today.</p><p>The result should be a leaner, meaner AT&amp;T that’s better equipped to face its challenges, but investors will want to see proof after feeling burned by years of management decisions that look poor in hindsight. Next up is a virtual investor day on March 11 focused on the post-WarnerMedia telecom business, which could include new long-term targets and plans.</p><p>The closing of the transaction itself should also bring some relief. Investors interested in Warner Bros. Discovery can shift to that stock, and those who want a yield-generating telecom stock can double down on AT&amp;T. Most of all, it will allow Wall Street to focus on AT&amp;T’s fundamentals and judge management on operations—and put an end to years of distracting and expensive M&amp;A sagas.</p></body></html>","source":"lsy1610680873436","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AT&T Is Getting Closer to a Clean Slate. Here’s What Comes Next</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAT&T Is Getting Closer to a Clean Slate. Here’s What Comes Next\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-02 08:36 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/att-media-spin-51643742609?mod=hp_LEAD_1><strong>Barron's</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After a saga of misguided M&A, there’s still work to be done for AT&T. Patrick T. Fallon/AFP via Getty ImagesAT&T shed some light on its pending exit from the media business on Tuesday, elaborating on...</p>\n\n<a href=\"https://www.barrons.com/articles/att-media-spin-51643742609?mod=hp_LEAD_1\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"T":"美国电话电报"},"source_url":"https://www.barrons.com/articles/att-media-spin-51643742609?mod=hp_LEAD_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1100073306","content_text":"After a saga of misguided M&A, there’s still work to be done for AT&T. Patrick T. Fallon/AFP via Getty ImagesAT&T shed some light on its pending exit from the media business on Tuesday, elaborating on the mechanics of this year’s mega-transaction to spin off WarnerMedia and merge it with Discovery. It’s one more step toward putting a saga of misguided M&A behind it, but there’s still work to be done.AT&T (ticker: T) spent much of the past decade bulking up and dishing out billions of dollars on several acquisitions. The biggest were a $66 billion deal for DirecTV, which closed in July 2015, and the $106 billion acquisition of Time Warner, which closed in June 2018. That brought the 145-year-old phone business into new and more cyclical industries, and at one point made it the most-indebted company in the U.S.Since the start of 2021 and under a new CEO, John Stankey, AT&T has been slimming down. A spinoff of DirecTV and the company’s other pay-TV operations was announced and completed last year. Its Xandr advertising platform is being sold to Microsoft ( MSFT ). And the spinoff of WarnerMedia should close in the second quarter of this year, per management.It will leave AT&T with a telecom-only portfolio of businesses focused on 5G wireless and fiber-optic broadband. Those are high fixed-cost businesses, but also bring attractive economies of scale and recurring revenue from subscribers.Shedding its conglomerate structure won’t make the challenges AT&T faces in its telecom businesses go away, but it will allow management to focus time and resources on solving them. Competitive dynamics in both wired and wireless communications appear to be getting more intense, especially as industry subscriber growth slows following a pandemic-era boost. And AT&T requires tens of billions of dollars in capital expenditures to improve its 5G and fiber networks.AT&T plans to expand its 5G C-band network to 200 million people in the U.S. by the end of 2023, and wants to reach 30 million homes and businesses with its fiber network by the end of 2025.AT&T will have more financial firepower to throw at those goals. Management expects $20 billion of annual free cash flow from the post-WarnerMedia telecom company, with 40% of that, or $8 billion, going toward its dividend. That compares with a $15 billion annual dividend commitment prior to the spinoff. The new payout will be some $1.11 per share annually, or a 6.3% yield at current prices (adjusting for the roughly $6.70 a share in Warner Bros. Discovery stock that AT&T holders will receive). It matches the projections that AT&T gave when announcing the transaction in May 2021.AT&T management expects to spend around $24 billion on capital investments in 2022. And the company will get an estimated $43 billion via the WarnerMedia transaction to put toward paying down debt. Management expects to get net debt to adjusted earnings before interest, taxes, depreciation, and amortization—or Ebitda—down to 2.5 times by the end of 2023. That compares with about 3.2 times today.The result should be a leaner, meaner AT&T that’s better equipped to face its challenges, but investors will want to see proof after feeling burned by years of management decisions that look poor in hindsight. Next up is a virtual investor day on March 11 focused on the post-WarnerMedia telecom business, which could include new long-term targets and plans.The closing of the transaction itself should also bring some relief. Investors interested in Warner Bros. Discovery can shift to that stock, and those who want a yield-generating telecom stock can double down on AT&T. Most of all, it will allow Wall Street to focus on AT&T’s fundamentals and judge management on operations—and put an end to years of distracting and expensive M&A sagas.","news_type":1},"isVote":1,"tweetType":1,"viewCount":628,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9091661999,"gmtCreate":1643853421813,"gmtModify":1676533863822,"author":{"id":"3582933493509774","authorId":"3582933493509774","name":"linghui","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582933493509774","authorIdStr":"3582933493509774"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9091661999","repostId":"1178657302","repostType":4,"repost":{"id":"1178657302","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1643804908,"share":"https://ttm.financial/m/news/1178657302?lang=&edition=fundamental","pubTime":"2022-02-02 20:28","market":"us","language":"en","title":"10 Biggest Price Target Changes For Wednesday","url":"https://stock-news.laohu8.com/highlight/detail?id=1178657302","media":"Benzinga","summary":"Keybanc lifted the price target for Alphabet Inc. from $3,090 to $3,400. Alphabet shares surged 11% ","content":"<html><head></head><body><ul><li>Keybanc lifted the price target for <b>Alphabet Inc.</b> from $3,090 to $3,400. Alphabet shares surged 11% to $3,055.00 in pre-market trading.</li><li>Wedbush cut the price target on <b>Starbucks Corporation</b> from $110 to $106. Starbucks shares fell 2.5% to $96.29 in pre-market trading.</li><li>Cowen &amp; Co. cut <b>Clover Health Investments, Corp.</b> price target from $7 to $3. Clover Health Investments shares rose 6.5% to $2.97 in pre-market trading.</li><li>UBS lowered <b>Zimmer Biomet Holdings, Inc.</b> price target from $172 to $130. Zimmer Biomet shares fell 0.2% to $123.80 in pre-market trading.</li><li>Citigroup cut <b>loanDepot, Inc.</b> price target from $12 to $5. loanDepot shares fell 4.9% to close at $4.46 on Tuesday.</li></ul><ul><li>Raymond James boosted the price target for <b>NXP Semiconductors N.V.</b> from $250 to $260. NXP Semiconductors shares rose 1.4% to $211.10 in pre-market trading.</li><li>SVB Leerink raised the price target on <b>Bio-Techne Corporation</b> from $530 to $575. Bio-Techne shares rose 0.1% to $401.76 in pre-market trading.</li><li>Goldman Sachs lowered <b>2U, Inc.</b> price target from $42 to $25. 2U shares rose 6.7% to $17.79 in pre-market trading.</li><li>UBS cut the price target on <b>Etsy, Inc.</b> from $215 to $180. Etsy shares rose 2% to $155.16 in pre-market trading.</li><li>Keybanc cut <b>PayPal Holdings, Inc.</b> price target from $250 to $200. PayPal shares fell 16% to $148.00 in pre-market trading.</li></ul></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>10 Biggest Price Target Changes For Wednesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n10 Biggest Price Target Changes For Wednesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2022-02-02 20:28</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><ul><li>Keybanc lifted the price target for <b>Alphabet Inc.</b> from $3,090 to $3,400. Alphabet shares surged 11% to $3,055.00 in pre-market trading.</li><li>Wedbush cut the price target on <b>Starbucks Corporation</b> from $110 to $106. Starbucks shares fell 2.5% to $96.29 in pre-market trading.</li><li>Cowen &amp; Co. cut <b>Clover Health Investments, Corp.</b> price target from $7 to $3. Clover Health Investments shares rose 6.5% to $2.97 in pre-market trading.</li><li>UBS lowered <b>Zimmer Biomet Holdings, Inc.</b> price target from $172 to $130. Zimmer Biomet shares fell 0.2% to $123.80 in pre-market trading.</li><li>Citigroup cut <b>loanDepot, Inc.</b> price target from $12 to $5. loanDepot shares fell 4.9% to close at $4.46 on Tuesday.</li></ul><ul><li>Raymond James boosted the price target for <b>NXP Semiconductors N.V.</b> from $250 to $260. NXP Semiconductors shares rose 1.4% to $211.10 in pre-market trading.</li><li>SVB Leerink raised the price target on <b>Bio-Techne Corporation</b> from $530 to $575. Bio-Techne shares rose 0.1% to $401.76 in pre-market trading.</li><li>Goldman Sachs lowered <b>2U, Inc.</b> price target from $42 to $25. 2U shares rose 6.7% to $17.79 in pre-market trading.</li><li>UBS cut the price target on <b>Etsy, Inc.</b> from $215 to $180. Etsy shares rose 2% to $155.16 in pre-market trading.</li><li>Keybanc cut <b>PayPal Holdings, Inc.</b> price target from $250 to $200. PayPal shares fell 16% to $148.00 in pre-market trading.</li></ul></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PYPL":"PayPal","ZBH":"齐默巴奥米特控股","SBUX":"星巴克","TWOU":"2U Inc","CLOV":"Clover Health Corp","LDI":"loanDepot, Inc.","GOOGL":"谷歌A","ETSY":"Etsy, Inc.","TECH":"Techne Corporation","NXPI":"恩智浦"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1178657302","content_text":"Keybanc lifted the price target for Alphabet Inc. from $3,090 to $3,400. Alphabet shares surged 11% to $3,055.00 in pre-market trading.Wedbush cut the price target on Starbucks Corporation from $110 to $106. Starbucks shares fell 2.5% to $96.29 in pre-market trading.Cowen & Co. cut Clover Health Investments, Corp. price target from $7 to $3. Clover Health Investments shares rose 6.5% to $2.97 in pre-market trading.UBS lowered Zimmer Biomet Holdings, Inc. price target from $172 to $130. Zimmer Biomet shares fell 0.2% to $123.80 in pre-market trading.Citigroup cut loanDepot, Inc. price target from $12 to $5. loanDepot shares fell 4.9% to close at $4.46 on Tuesday.Raymond James boosted the price target for NXP Semiconductors N.V. from $250 to $260. NXP Semiconductors shares rose 1.4% to $211.10 in pre-market trading.SVB Leerink raised the price target on Bio-Techne Corporation from $530 to $575. Bio-Techne shares rose 0.1% to $401.76 in pre-market trading.Goldman Sachs lowered 2U, Inc. price target from $42 to $25. 2U shares rose 6.7% to $17.79 in pre-market trading.UBS cut the price target on Etsy, Inc. from $215 to $180. Etsy shares rose 2% to $155.16 in pre-market trading.Keybanc cut PayPal Holdings, Inc. price target from $250 to $200. PayPal shares fell 16% to $148.00 in pre-market trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":336,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9091660170,"gmtCreate":1643852941827,"gmtModify":1676533863751,"author":{"id":"3582933493509774","authorId":"3582933493509774","name":"linghui","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582933493509774","authorIdStr":"3582933493509774"},"themes":[],"htmlText":"Thanks","listText":"Thanks","text":"Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9091660170","repostId":"1196109622","repostType":4,"repost":{"id":"1196109622","kind":"news","pubTimestamp":1643852105,"share":"https://ttm.financial/m/news/1196109622?lang=&edition=fundamental","pubTime":"2022-02-03 09:35","market":"us","language":"en","title":"2 Biotech Stocks That Could Make You Richer","url":"https://stock-news.laohu8.com/highlight/detail?id=1196109622","media":"Motley Fool","summary":"Investing in the stock market won't make you rich overnight. But with a patient approach to investin","content":"<html><head></head><body><p>Investing in the stock market won&#39;t make you rich overnight. But with a patient approach to investing, coupled with several promising picks that could perform well in the long run, you can become much wealthier by investing in stocks over time.</p><p>Let&#39;s address the second part of this strategy: picking the right stocks, which isn&#39;t always an easy task. If you need some inspiration, here are two biotech stocks that are currently down and out with investors -- and while they carry some risk, I believe they have the potential to deliver strong returns to the patient shareholder: <a href=\"https://laohu8.com/S/BLUE\"><b>Bluebird Bio</b></a> and <a href=\"https://laohu8.com/S/EXEL\"><b>Exelixis</b></a>. Here&#39;s why.</p><p>1. <a href=\"https://laohu8.com/S/BLUE\"><b>Bluebird Bio</b></a></p><p>To say that Bluebird Bio has lagged the market in the past year would be an understatement. The gene-editing specialist has lost over 70% of its value in the trailing-12-month period, a horrible performance by any metric. The company owes this poor showing to a combination of factors, but as is usual with biotech companies, clinical and regulatory setbacks played a significant role.</p><p>On the positive side, Bluebird has proven that it can earn regulatory nods for multiple therapies -- few other gene-editing companies can say the same. Both Skysona, a treatment for a pediatric neurodegenerative disorder called cerebral adrenoleukodystrophy (CALD), and Zynteglo, a therapy for the blood disorder transfusion-dependent beta-thalassemia (TDT), were approved in Europe.</p><p>However, the company opted to leave the European market after failing to land a good deal with third-party payers for its approved gene-editing treatments. It also has had to pause a couple of clinical trials because of suspected adverse reactions. And it recently spun off its oncology business into a separate entity called<b>2Seventy Bio</b>.</p><p>Where does that leave Bluebird? It leaves the biotech with a pipeline focused on rare illnesses and some promising programs on the way. In September, the company submitted an application to the U.S. Food and Drug Administration for beti-cel, a treatment for TDT that was branded as Zynteglo in Europe.</p><p>There are few treatments for TDT. But Bluebird&#39;s version of the therapy that was approved in Europe costs a hefty 1.58 million euros. The biotech will almost certainly set a high price in the U.S. as well if beti-cel gets approved. There is no denying the value it would bring to patients: a one-time, curative treatment for a disorder that would otherwise require regular blood transfusions for survival.</p><p>The company has also submitted a U.S. application for eli-cel, a treatment for CALD that was approved in Europe this past December as Skysona. The FDA granted eli-cel priority review, which is reserved for therapies that could be an improvement over existing treatments. CALD is the most severe form of adrenoleukodystrophy (ALD).</p><p>ALD itself is pretty rare, and 40% of boys diagnosed with it end up developing CALD. The only known treatment for this illness is a stem-cell transplant. Eli-cel and beti-cel could both be approved this year with the potential to generate at least several hundred million dollars in peak annual sales -- if not significantly more.</p><p>Bluebird looks a bit on the risky side. It currently has no products on the market and is consistently unprofitable. And the biotech could run into even more regulatory headwinds, which would sink its stock even further.</p><p>However, Bluebird&#39;s current market cap is barely over $500 million. The market isn&#39;t putting much value in the company&#39;s programs at all. That&#39;s what makes this biotech a potentially attractive option. If the company&#39;s master plan actualizes, its shares could skyrocket.</p><p>2. <a href=\"https://laohu8.com/S/EXEL\"><b>Exelixis</b></a></p><p>Exelixis is best-known for its cancer medicine Cabometyx, approved for renal cell carcinoma (RCC) and hepatocellular carcinoma (HCC). In fact, it represents the bulk of the company&#39;s sales. But thebiotech&#39;s reliance on its crown jewel doesn&#39;t bode well for many investors, which partly explains why the company has lagged the market -- down some 18% over the past year.</p><p>Still, there is hope for Exelixis, which will report its full financial results on Feb. 17.</p><p>First, Cabometyx has continued to increase its sales while grinding out more indications. Exelixis recently announced preliminary results for last year. For the fourth quarter, it expects an 11.1% year-over-year increase in revenue to $300 million -- a solid performance. For the full year, it&#39;s estimating $1.08 billion in revenue, an increase of 9.4%. And for 2022, it&#39;s predicting $1.3 billion to $1.4 billion in revenue.</p><p>Cabometyx is also still being tested in dozens of clinical trials. Results from several phase 3 studies should come in this year, so the cancer medicine could once again earn label expansions. That&#39;s good news for Exelixis and its shareholders.</p><p>The biotech is now looking to replicate the success it&#39;s had with Cabometyx. It&#39;s advancing several pipeline candidates through early-stage clinical trials, including a trio of cancer therapies: XL092, XL102, and XB002. The company will update investors on the progress of these programs this year, and these updates could help send its stock price higher.</p><p>Within the next couple of years, these products should be moving into late-stage studies. Exelixis&#39; forward price-to-earnings ratio of about 15 -- while higher than the industry average of 11 -- is about as low as it has been in over two years. In the long run, Exelixis should rebound from its recent woes, and it might be worth adding shares of the company right now.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Biotech Stocks That Could Make You Richer</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Biotech Stocks That Could Make You Richer\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-03 09:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/02/02/2-biotech-stocks-that-could-make-you-richer/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Investing in the stock market won't make you rich overnight. But with a patient approach to investing, coupled with several promising picks that could perform well in the long run, you can become much...</p>\n\n<a href=\"https://www.fool.com/investing/2022/02/02/2-biotech-stocks-that-could-make-you-richer/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"EXEL":"伊克力西斯","BLUE":"bluebird bio Inc."},"source_url":"https://www.fool.com/investing/2022/02/02/2-biotech-stocks-that-could-make-you-richer/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1196109622","content_text":"Investing in the stock market won't make you rich overnight. But with a patient approach to investing, coupled with several promising picks that could perform well in the long run, you can become much wealthier by investing in stocks over time.Let's address the second part of this strategy: picking the right stocks, which isn't always an easy task. If you need some inspiration, here are two biotech stocks that are currently down and out with investors -- and while they carry some risk, I believe they have the potential to deliver strong returns to the patient shareholder: Bluebird Bio and Exelixis. Here's why.1. Bluebird BioTo say that Bluebird Bio has lagged the market in the past year would be an understatement. The gene-editing specialist has lost over 70% of its value in the trailing-12-month period, a horrible performance by any metric. The company owes this poor showing to a combination of factors, but as is usual with biotech companies, clinical and regulatory setbacks played a significant role.On the positive side, Bluebird has proven that it can earn regulatory nods for multiple therapies -- few other gene-editing companies can say the same. Both Skysona, a treatment for a pediatric neurodegenerative disorder called cerebral adrenoleukodystrophy (CALD), and Zynteglo, a therapy for the blood disorder transfusion-dependent beta-thalassemia (TDT), were approved in Europe.However, the company opted to leave the European market after failing to land a good deal with third-party payers for its approved gene-editing treatments. It also has had to pause a couple of clinical trials because of suspected adverse reactions. And it recently spun off its oncology business into a separate entity called2Seventy Bio.Where does that leave Bluebird? It leaves the biotech with a pipeline focused on rare illnesses and some promising programs on the way. In September, the company submitted an application to the U.S. Food and Drug Administration for beti-cel, a treatment for TDT that was branded as Zynteglo in Europe.There are few treatments for TDT. But Bluebird's version of the therapy that was approved in Europe costs a hefty 1.58 million euros. The biotech will almost certainly set a high price in the U.S. as well if beti-cel gets approved. There is no denying the value it would bring to patients: a one-time, curative treatment for a disorder that would otherwise require regular blood transfusions for survival.The company has also submitted a U.S. application for eli-cel, a treatment for CALD that was approved in Europe this past December as Skysona. The FDA granted eli-cel priority review, which is reserved for therapies that could be an improvement over existing treatments. CALD is the most severe form of adrenoleukodystrophy (ALD).ALD itself is pretty rare, and 40% of boys diagnosed with it end up developing CALD. The only known treatment for this illness is a stem-cell transplant. Eli-cel and beti-cel could both be approved this year with the potential to generate at least several hundred million dollars in peak annual sales -- if not significantly more.Bluebird looks a bit on the risky side. It currently has no products on the market and is consistently unprofitable. And the biotech could run into even more regulatory headwinds, which would sink its stock even further.However, Bluebird's current market cap is barely over $500 million. The market isn't putting much value in the company's programs at all. That's what makes this biotech a potentially attractive option. If the company's master plan actualizes, its shares could skyrocket.2. ExelixisExelixis is best-known for its cancer medicine Cabometyx, approved for renal cell carcinoma (RCC) and hepatocellular carcinoma (HCC). In fact, it represents the bulk of the company's sales. But thebiotech's reliance on its crown jewel doesn't bode well for many investors, which partly explains why the company has lagged the market -- down some 18% over the past year.Still, there is hope for Exelixis, which will report its full financial results on Feb. 17.First, Cabometyx has continued to increase its sales while grinding out more indications. Exelixis recently announced preliminary results for last year. For the fourth quarter, it expects an 11.1% year-over-year increase in revenue to $300 million -- a solid performance. For the full year, it's estimating $1.08 billion in revenue, an increase of 9.4%. And for 2022, it's predicting $1.3 billion to $1.4 billion in revenue.Cabometyx is also still being tested in dozens of clinical trials. Results from several phase 3 studies should come in this year, so the cancer medicine could once again earn label expansions. That's good news for Exelixis and its shareholders.The biotech is now looking to replicate the success it's had with Cabometyx. It's advancing several pipeline candidates through early-stage clinical trials, including a trio of cancer therapies: XL092, XL102, and XB002. The company will update investors on the progress of these programs this year, and these updates could help send its stock price higher.Within the next couple of years, these products should be moving into late-stage studies. Exelixis' forward price-to-earnings ratio of about 15 -- while higher than the industry average of 11 -- is about as low as it has been in over two years. In the long run, Exelixis should rebound from its recent woes, and it might be worth adding shares of the company right now.","news_type":1},"isVote":1,"tweetType":1,"viewCount":363,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9091972866,"gmtCreate":1643768833295,"gmtModify":1676533853931,"author":{"id":"3582933493509774","authorId":"3582933493509774","name":"linghui","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582933493509774","authorIdStr":"3582933493509774"},"themes":[],"htmlText":"Ok&nbsp;","listText":"Ok&nbsp;","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9091972866","repostId":"2208351417","repostType":4,"repost":{"id":"2208351417","kind":"news","pubTimestamp":1643758197,"share":"https://ttm.financial/m/news/2208351417?lang=&edition=fundamental","pubTime":"2022-02-02 07:29","market":"us","language":"en","title":"Starbucks Shares Down 1% on Q4 EPS Miss; Revenues Better Than Expected","url":"https://stock-news.laohu8.com/highlight/detail?id=2208351417","media":"StreetInsider","summary":"Starbucks (NASDAQ: SBUX) shares were trading around 1% lower after-hours following the company’s Q1 ","content":"<html><head></head><body><p>Starbucks (NASDAQ: SBUX) shares were trading around 1% lower after-hours following the company’s Q1 results, with EPS of $0.72 missing the Street estimate of $0.79, while revenue growing 19% to $8.1 billion, beating the consensus of $7.97 billion.</p><p><img src=\"https://static.tigerbbs.com/43f905e68c4e641a8af42264a8c6ed63\" tg-width=\"921\" tg-height=\"730\" width=\"100%\" height=\"auto\"/></p><p>The revenue growth was primarily driven by a 13% growth in comparable store sales mainly from lapping the unfavorable impact of business disruption in 2020 due to the COVID-19 pandemic and strength of new U.S. company-operated stores compared to 2020 performance of stores closed as a part of the company’s North America Trade Area Transformation.</p><p>The company reported a global comparable store sales growth of 13%, driven by a 10% increase in comparable transactions and a 3% increase in average ticket. 484 net new stores were opened during the quarter, representing a 4% year-over-year unit growth, closing the year with a record 34,317 stores globally.</p></body></html>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Starbucks Shares Down 1% on Q4 EPS Miss; Revenues Better Than Expected</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStarbucks Shares Down 1% on Q4 EPS Miss; Revenues Better Than Expected\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-02 07:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19541534><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Starbucks (NASDAQ: SBUX) shares were trading around 1% lower after-hours following the company’s Q1 results, with EPS of $0.72 missing the Street estimate of $0.79, while revenue growing 19% to $8.1 ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19541534\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SBUX":"星巴克"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19541534","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2208351417","content_text":"Starbucks (NASDAQ: SBUX) shares were trading around 1% lower after-hours following the company’s Q1 results, with EPS of $0.72 missing the Street estimate of $0.79, while revenue growing 19% to $8.1 billion, beating the consensus of $7.97 billion.The revenue growth was primarily driven by a 13% growth in comparable store sales mainly from lapping the unfavorable impact of business disruption in 2020 due to the COVID-19 pandemic and strength of new U.S. company-operated stores compared to 2020 performance of stores closed as a part of the company’s North America Trade Area Transformation.The company reported a global comparable store sales growth of 13%, driven by a 10% increase in comparable transactions and a 3% increase in average ticket. 484 net new stores were opened during the quarter, representing a 4% year-over-year unit growth, closing the year with a record 34,317 stores globally.","news_type":1},"isVote":1,"tweetType":1,"viewCount":495,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9091976377,"gmtCreate":1643768778805,"gmtModify":1676533853907,"author":{"id":"3582933493509774","authorId":"3582933493509774","name":"linghui","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582933493509774","authorIdStr":"3582933493509774"},"themes":[],"htmlText":"Gd info","listText":"Gd info","text":"Gd info","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9091976377","repostId":"1181481003","repostType":4,"repost":{"id":"1181481003","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1643722728,"share":"https://ttm.financial/m/news/1181481003?lang=&edition=fundamental","pubTime":"2022-02-01 21:38","market":"us","language":"en","title":"MicroStrategy shares rose 7% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1181481003","media":"Tiger Newspress","summary":"MicroStrategy shares rose 7% in premarket trading.As of Jan. 31, the company held about 125,051 bitc","content":"<html><head></head><body><p>MicroStrategy shares rose 7% in premarket trading.<img src=\"https://static.tigerbbs.com/9682bd3ba54feb42c63bc9be06e419fa\" tg-width=\"699\" tg-height=\"598\" width=\"100%\" height=\"auto\"/></p><p>As of Jan. 31, the company held about 125,051 bitcoins purchased at an average price of $30,200.</p><p>MicroStrategy (Nasdaq: MSTR), the business-intelligence software company that’s taken to accumulating bitcoin, said it bought approximately 660 bitcoins for around $25 million between Dec. 30, 2021 and Jan. 31, 2022.</p><p>The company paid an average price of $37,865 per bitcoin, it said in a statement.</p><p>Tysons Corner, Virginia-based MicroStrategy now holds a total of 125,051 bitcoins, valued at about $4.8 billion at the current bitcoin price of $38,700.</p><p>Shares of MicroStrategy have fallen around 34% over the last month.</p><p>CEO Michael Saylor has been insistent that the company has no plans to sell its bitcoin holdings and is in for the long-term.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MicroStrategy shares rose 7% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMicroStrategy shares rose 7% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-02-01 21:38</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>MicroStrategy shares rose 7% in premarket trading.<img src=\"https://static.tigerbbs.com/9682bd3ba54feb42c63bc9be06e419fa\" tg-width=\"699\" tg-height=\"598\" width=\"100%\" height=\"auto\"/></p><p>As of Jan. 31, the company held about 125,051 bitcoins purchased at an average price of $30,200.</p><p>MicroStrategy (Nasdaq: MSTR), the business-intelligence software company that’s taken to accumulating bitcoin, said it bought approximately 660 bitcoins for around $25 million between Dec. 30, 2021 and Jan. 31, 2022.</p><p>The company paid an average price of $37,865 per bitcoin, it said in a statement.</p><p>Tysons Corner, Virginia-based MicroStrategy now holds a total of 125,051 bitcoins, valued at about $4.8 billion at the current bitcoin price of $38,700.</p><p>Shares of MicroStrategy have fallen around 34% over the last month.</p><p>CEO Michael Saylor has been insistent that the company has no plans to sell its bitcoin holdings and is in for the long-term.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MSTR":"MicroStrategy"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1181481003","content_text":"MicroStrategy shares rose 7% in premarket trading.As of Jan. 31, the company held about 125,051 bitcoins purchased at an average price of $30,200.MicroStrategy (Nasdaq: MSTR), the business-intelligence software company that’s taken to accumulating bitcoin, said it bought approximately 660 bitcoins for around $25 million between Dec. 30, 2021 and Jan. 31, 2022.The company paid an average price of $37,865 per bitcoin, it said in a statement.Tysons Corner, Virginia-based MicroStrategy now holds a total of 125,051 bitcoins, valued at about $4.8 billion at the current bitcoin price of $38,700.Shares of MicroStrategy have fallen around 34% over the last month.CEO Michael Saylor has been insistent that the company has no plans to sell its bitcoin holdings and is in for the long-term.","news_type":1},"isVote":1,"tweetType":1,"viewCount":399,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9092993723,"gmtCreate":1644504373762,"gmtModify":1676533934446,"author":{"id":"3582933493509774","authorId":"3582933493509774","name":"linghui","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582933493509774","authorIdStr":"3582933493509774"},"themes":[],"htmlText":"sigh","listText":"sigh","text":"sigh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9092993723","repostId":"696619638","repostType":1,"repost":{"id":696619638,"gmtCreate":1640679651873,"gmtModify":1676532477490,"author":{"id":"9000000000000695","authorId":"9000000000000695","name":"BaronLyly","avatar":"https://static.tigerbbs.com/2002537f0b7be973a9a9a72fea618459","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"9000000000000695","authorIdStr":"9000000000000695"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MARA\">$Marathon Digital Holdings Inc(MARA)$</a> you won’t see much growth here . You should be banking on FRTTF<a href=\"https://laohu8.com/S/FRTTF\">$FORTRESS TECHNOLOGIES INC.(FRTTF)$</a> and LUXXF<a href=\"https://laohu8.com/S/LUXFF\">$LUXXFOLIO HLDGS INC(LUXFF)$</a> as they will double , triple and very cheap . I bought MARA and RIOT<a href=\"https://laohu8.com/S/RIOT\">$Riot Blockchain, Inc.(RIOT)$</a> as a penny stock last year so jump on same. Easier to double and triple your money if you buy low hanging fruit .looks like accumulation before the next leg up","listText":"<a href=\"https://laohu8.com/S/MARA\">$Marathon Digital Holdings Inc(MARA)$</a> you won’t see much growth here . You should be banking on FRTTF<a href=\"https://laohu8.com/S/FRTTF\">$FORTRESS TECHNOLOGIES INC.(FRTTF)$</a> and LUXXF<a href=\"https://laohu8.com/S/LUXFF\">$LUXXFOLIO HLDGS INC(LUXFF)$</a> as they will double , triple and very cheap . I bought MARA and RIOT<a href=\"https://laohu8.com/S/RIOT\">$Riot Blockchain, Inc.(RIOT)$</a> as a penny stock last year so jump on same. Easier to double and triple your money if you buy low hanging fruit .looks like accumulation before the next leg up","text":"$Marathon Digital Holdings Inc(MARA)$ you won’t see much growth here . You should be banking on FRTTF$FORTRESS TECHNOLOGIES INC.(FRTTF)$ and LUXXF$LUXXFOLIO HLDGS INC(LUXFF)$ as they will double , triple and very cheap . I bought MARA and RIOT$Riot Blockchain, Inc.(RIOT)$ as a penny stock last year so jump on same. Easier to double and triple your money if you buy low hanging fruit .looks like accumulation before the next leg up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/696619638","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":855,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9098309708,"gmtCreate":1644020507382,"gmtModify":1676533881869,"author":{"id":"3582933493509774","authorId":"3582933493509774","name":"linghui","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582933493509774","authorIdStr":"3582933493509774"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9098309708","repostId":"2209345239","repostType":4,"repost":{"id":"2209345239","kind":"news","pubTimestamp":1644016922,"share":"https://ttm.financial/m/news/2209345239?lang=&edition=fundamental","pubTime":"2022-02-05 07:22","market":"us","language":"en","title":"Apple Aims to Debut a New Low-Cost 5G iPhone and iPad in Early March","url":"https://stock-news.laohu8.com/highlight/detail?id=2209345239","media":"Bloomberg","summary":"Apple Inc. is targeting a date on or near March 8 to unveil a new low-cost iPhone and an updated iPad, according to people with knowledge of the matter, kicking off a potentially record-setting year f","content":"<html><head></head><body><p>Apple Inc. is targeting a date on or near March 8 to unveil a new low-cost iPhone and an updated iPad, according to people with knowledge of the matter, kicking off a potentially record-setting year for product launches.</p><p>The announcement will mark Apple’s first major event since a new MacBook Pro debuted in October. Like the company’s other recent launches, it’s expected to be an online presentation rather than in-person, said the people, who asked not to be identified because the deliberations are private.</p><p>Apple is coming off a holiday quarter that far exceeded Wall Street predictions, helping quell fears that supply-chain problems would hurt sales. Now the company is setting its sights higher for 2022. The March announcements -- along with the usual flood of product news expected later in 2022 -- suggest Apple will introduce its biggest crop of new devices ever in a single year.</p><p>Given that the planned timing is still more than a month away, the company’s plans may change in the face of production delays or other changes, the people said. An Apple spokeswoman declined to comment on the company’s plans.</p><p>The new phone will be the first update to the iPhone SE model in two years, adding 5G network capabilities, an improved camera and a faster processor. But the design itself is expected to be similar to the current version, which debuted in April 2020.</p><p>The new iPad, meanwhile, will be an update to the Air model that features a faster processor and 5G. The company is also planning a new Mac with Apple-designed chips, which could also come as early as March.</p><p>In addition to announcing new devices, the company is planning to release iOS 15.4 in the first half of March, the people said. The software update will add Face ID support for people wearing masks to iPhones and iPads, making it easier for users to unlock their devices. It also has new emojis and Universal Control, which lets customers use a single keyboard and trackpad across multiple iPads and Macs.</p><p>Following the March event, the company will likely hold its annual Worldwide Developers Conference in June to announce software updates for the iPhone, iPad, Mac and Apple Watch. It’s then expected to hold multiple keynote events in the fall to launch the iPhone 14 and new Macs.</p><p>The 2022 lineup is likely to include new iMac and Mac Pro desktops, a redesigned MacBook Air, an updated low-end MacBook Pro, three Apple Watches, four iPhone 14 models and new AirPods. The company is also planning new services, such as a feature that lets the iPhone accept payments with the tap of a credit card.</p><p>Apple is working on a high-end mixed reality headset as well, but that’s now more likely to be released in 2023. The company had aimed to announce the device as early as the end of 2022, but development challenges have delayed the timing, Bloomberg reported last month.</p></body></html>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple Aims to Debut a New Low-Cost 5G iPhone and iPad in Early March</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple Aims to Debut a New Low-Cost 5G iPhone and iPad in Early March\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-05 07:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/apple-aims-debut-low-cost-193822024.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Apple Inc. is targeting a date on or near March 8 to unveil a new low-cost iPhone and an updated iPad, according to people with knowledge of the matter, kicking off a potentially record-setting year ...</p>\n\n<a href=\"https://finance.yahoo.com/news/apple-aims-debut-low-cost-193822024.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NGD":"New Gold","BK4527":"明星科技股","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4550":"红杉资本持仓","AAPL":"苹果","BK4554":"元宇宙及AR概念","BK4566":"资本集团","BK4515":"5G概念","BK4532":"文艺复兴科技持仓","BK4501":"段永平概念","BK4505":"高瓴资本持仓","BK4553":"喜马拉雅资本持仓","BK4507":"流媒体概念","BK4170":"电脑硬件、储存设备及电脑周边","BK4559":"巴菲特持仓","BK4017":"黄金","BK4534":"瑞士信贷持仓"},"source_url":"https://finance.yahoo.com/news/apple-aims-debut-low-cost-193822024.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2209345239","content_text":"Apple Inc. is targeting a date on or near March 8 to unveil a new low-cost iPhone and an updated iPad, according to people with knowledge of the matter, kicking off a potentially record-setting year for product launches.The announcement will mark Apple’s first major event since a new MacBook Pro debuted in October. Like the company’s other recent launches, it’s expected to be an online presentation rather than in-person, said the people, who asked not to be identified because the deliberations are private.Apple is coming off a holiday quarter that far exceeded Wall Street predictions, helping quell fears that supply-chain problems would hurt sales. Now the company is setting its sights higher for 2022. The March announcements -- along with the usual flood of product news expected later in 2022 -- suggest Apple will introduce its biggest crop of new devices ever in a single year.Given that the planned timing is still more than a month away, the company’s plans may change in the face of production delays or other changes, the people said. An Apple spokeswoman declined to comment on the company’s plans.The new phone will be the first update to the iPhone SE model in two years, adding 5G network capabilities, an improved camera and a faster processor. But the design itself is expected to be similar to the current version, which debuted in April 2020.The new iPad, meanwhile, will be an update to the Air model that features a faster processor and 5G. The company is also planning a new Mac with Apple-designed chips, which could also come as early as March.In addition to announcing new devices, the company is planning to release iOS 15.4 in the first half of March, the people said. The software update will add Face ID support for people wearing masks to iPhones and iPads, making it easier for users to unlock their devices. It also has new emojis and Universal Control, which lets customers use a single keyboard and trackpad across multiple iPads and Macs.Following the March event, the company will likely hold its annual Worldwide Developers Conference in June to announce software updates for the iPhone, iPad, Mac and Apple Watch. It’s then expected to hold multiple keynote events in the fall to launch the iPhone 14 and new Macs.The 2022 lineup is likely to include new iMac and Mac Pro desktops, a redesigned MacBook Air, an updated low-end MacBook Pro, three Apple Watches, four iPhone 14 models and new AirPods. The company is also planning new services, such as a feature that lets the iPhone accept payments with the tap of a credit card.Apple is working on a high-end mixed reality headset as well, but that’s now more likely to be released in 2023. The company had aimed to announce the device as early as the end of 2022, but development challenges have delayed the timing, Bloomberg reported last month.","news_type":1},"isVote":1,"tweetType":1,"viewCount":469,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9095302361,"gmtCreate":1644813840775,"gmtModify":1676533964421,"author":{"id":"3582933493509774","authorId":"3582933493509774","name":"linghui","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582933493509774","authorIdStr":"3582933493509774"},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9095302361","repostId":"9092755406","repostType":1,"repost":{"id":9092755406,"gmtCreate":1644742715482,"gmtModify":1676533958368,"author":{"id":"3527667591235607","authorId":"3527667591235607","name":"OptionPlus","avatar":"https://static.tigerbbs.com/e8009c23927adcf8b5e1e1d101178392","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3527667591235607","authorIdStr":"3527667591235607"},"themes":[],"title":"Option Recap: Don't take chestnuts out of the fire","htmlText":"The general idea is similar to last week, so I dont do detailed review，you can read&nbsp;my&nbsp;review&nbsp;for&nbsp;last&nbsp;week&nbsp;if&nbsp;you&nbsp;like. The&nbsp;S&amp;P&nbsp;500&nbsp;fell&nbsp;be&nbsp;its&nbsp;anual&nbsp;support&nbsp;line&nbsp;again&nbsp;in&nbsp;the&nbsp;second&nbsp;half&nbsp;of&nbsp;Friday&nbsp;night&nbsp;with&nbsp;geopolitical shocks.&nbsp;And&nbsp;It&nbsp;closed&nbsp;at&nbsp;a&nbsp;weely&nbsp;low&nbsp;point.&nbsp;My&nbsp;feeling&nbsp;is&nbsp;similar&nbsp;to&nbsp;last&nbsp;week,&nbsp;it&nbsp;might&nbsp;draw&nbsp;a&nbsp;right-leg. There&nbsp;is&nbsp;a&nbsp;small&nbsp;double-top&nbsp;in&nbsp;past&nbsp;two&nbsp;weeks,&nbsp;and&nbsp;both&nbsp;small&nbsp;tops&nbsp;did&nbsp;not&nbsp;rally&nbsp;to&nbsp;the&nbsp;MA50,&nbsp;it&nbsp;was&nbsp;not&nbsp;strong.&nbsp;As&nbsp;","listText":"The general idea is similar to last week, so I dont do detailed review，you can read&nbsp;my&nbsp;review&nbsp;for&nbsp;last&nbsp;week&nbsp;if&nbsp;you&nbsp;like. The&nbsp;S&amp;P&nbsp;500&nbsp;fell&nbsp;be&nbsp;its&nbsp;anual&nbsp;support&nbsp;line&nbsp;again&nbsp;in&nbsp;the&nbsp;second&nbsp;half&nbsp;of&nbsp;Friday&nbsp;night&nbsp;with&nbsp;geopolitical shocks.&nbsp;And&nbsp;It&nbsp;closed&nbsp;at&nbsp;a&nbsp;weely&nbsp;low&nbsp;point.&nbsp;My&nbsp;feeling&nbsp;is&nbsp;similar&nbsp;to&nbsp;last&nbsp;week,&nbsp;it&nbsp;might&nbsp;draw&nbsp;a&nbsp;right-leg. There&nbsp;is&nbsp;a&nbsp;small&nbsp;double-top&nbsp;in&nbsp;past&nbsp;two&nbsp;weeks,&nbsp;and&nbsp;both&nbsp;small&nbsp;tops&nbsp;did&nbsp;not&nbsp;rally&nbsp;to&nbsp;the&nbsp;MA50,&nbsp;it&nbsp;was&nbsp;not&nbsp;strong.&nbsp;As&nbsp;","text":"The general idea is similar to last week, so I dont do detailed review，you can read my review for last week if you like. The S&P 500 fell be its anual support line again in the second half of Friday night with geopolitical shocks. And It closed at a weely low point. My feeling is similar to last week, it might draw a right-leg. There is a small double-top in past two weeks, and both small tops did not rally to the MA50, it was not strong. As","images":[{"img":"https://static.tigerbbs.com/ed0379ee21b4ee0665a09e0210e754a4","width":"2096","height":"1220"},{"img":"https://static.tigerbbs.com/cbe5974fdf018ff5b17c62544ec1de99","width":"2144","height":"1534"},{"img":"https://static.tigerbbs.com/cc0af868946c5e3165b2c5dad80913e6","width":"2198","height":"1332"}],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9092755406","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":3,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":476,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9098309592,"gmtCreate":1644020478679,"gmtModify":1676533881861,"author":{"id":"3582933493509774","authorId":"3582933493509774","name":"linghui","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582933493509774","authorIdStr":"3582933493509774"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9098309592","repostId":"1133568920","repostType":4,"repost":{"id":"1133568920","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1643879102,"share":"https://ttm.financial/m/news/1133568920?lang=&edition=fundamental","pubTime":"2022-02-03 17:05","market":"us","language":"en","title":"Metauniverse Stocks Slid in Premarket Trading,With Block and Roblox Falling Over 6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1133568920","media":"Tiger Newspress","summary":"Metauniverse stocks slid in premarket trading, with Block and Roblox falling over6%.In Meta’s financ","content":"<html><head></head><body><p>Metauniverse stocks slid in premarket trading, with Block and Roblox falling over6%.</p><p><img src=\"https://static.tigerbbs.com/9bf35520675a25a430afdadb73298193\" tg-width=\"287\" tg-height=\"191\" referrerpolicy=\"no-referrer\"/></p><p>In Meta’s financial result ,it disclosed the data of FRL department including metauniverse strategy for the first time. The company expected that the investment in metauniverse will reduce the operating profit by about US $10 billion in 2021, and FRL will not make a profit in the short term.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Metauniverse Stocks Slid in Premarket Trading,With Block and Roblox Falling Over 6%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMetauniverse Stocks Slid in Premarket Trading,With Block and Roblox Falling Over 6%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-02-03 17:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Metauniverse stocks slid in premarket trading, with Block and Roblox falling over6%.</p><p><img src=\"https://static.tigerbbs.com/9bf35520675a25a430afdadb73298193\" tg-width=\"287\" tg-height=\"191\" referrerpolicy=\"no-referrer\"/></p><p>In Meta’s financial result ,it disclosed the data of FRL department including metauniverse strategy for the first time. The company expected that the investment in metauniverse will reduce the operating profit by about US $10 billion in 2021, and FRL will not make a profit in the short term.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"RBLX":"Roblox Corporation","SQ":"Block"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1133568920","content_text":"Metauniverse stocks slid in premarket trading, with Block and Roblox falling over6%.In Meta’s financial result ,it disclosed the data of FRL department including metauniverse strategy for the first time. The company expected that the investment in metauniverse will reduce the operating profit by about US $10 billion in 2021, and FRL will not make a profit in the short term.","news_type":1},"isVote":1,"tweetType":1,"viewCount":466,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9091978587,"gmtCreate":1643768729351,"gmtModify":1676533853898,"author":{"id":"3582933493509774","authorId":"3582933493509774","name":"linghui","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582933493509774","authorIdStr":"3582933493509774"},"themes":[],"htmlText":"Above ok!","listText":"Above ok!","text":"Above ok!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9091978587","repostId":"2208633473","repostType":4,"repost":{"id":"2208633473","kind":"highlight","pubTimestamp":1643721720,"share":"https://ttm.financial/m/news/2208633473?lang=&edition=fundamental","pubTime":"2022-02-01 21:22","market":"us","language":"en","title":"5 High-Yield Dividend Stocks That Can Save Your Portfolio During a Stock Market Crash","url":"https://stock-news.laohu8.com/highlight/detail?id=2208633473","media":"Motley Fool","summary":"These income stocks, with yields ranging from 4.1% to 11.3%, can be your rock during periods of heightened volatility.","content":"<html><head></head><body><p>January provided a not-so-subtle reminder that stock market crashes and corrections are a normal part of the investing cycle, and they can occur without warning. Both the benchmark <b>S&amp;P 500</b> and growth stock-driven <b>Nasdaq Composite</b> endured their steepest corrections in close to two years.</p><p>While steep moves lower in the market in a short time frame can be unnerving, arguably <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the smartest ways to save your portfolio from these periods of heightened volatility is to buy high-yield dividend stocks (i.e., those with yields of 4% or above).</p><p>Dividend stocks offer a number of advantages to investors. For instance, companies that pay a dividend are often profitable on a recurring basis and time-tested. Additionally, income stocks have a rich history of handily outperforming their non-dividend-paying peers.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/19e231762b394073ae50eae89896fa40\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"/><span>Image source: Getty Images.</span></p><p>If this recent sell-off does turn into a full-blown stock market crash, the following high-yield dividend stocks can be your saviors.</p><h2>AT&amp;T: 8.3% yield</h2><p>If you crave stability, telecom stocks like <b>AT&amp;T</b> (NYSE:T) are a good place to find it. AT&amp;T has two key catalysts that can deliver modest organic growth over the next half decade, all while the company parses out an above-average payout.</p><p>For starters, ongoing upgrades to 5G wireless infrastructure are going to be a big deal. Even though the investments AT&amp;T is making in wireless infrastructure are sizable, consumers and businesses have been waiting a decade for an upgrade to wireless download speeds. The rollout of 5G speeds in the U.S. should encourage businesses and consumers to replace their devices over the coming years. Since data is what drives AT&amp;T&#39;s juicy wireless margins, faster download speeds can increase the wireless segment growth rate.</p><p>The other growth catalyst for AT&amp;T is the expected spinoff of content arm WarnerMedia, which will be merged with <b>Discovery</b>. This new media entity will offer a larger content library with over 85 million pro forma subscribers, and should result in at least $3 billion in annual cost synergies. Most importantly, AT&amp;T will be able to modestly reduce its dividend following the spinoff and focus on debt reduction. Even after this dividend cut, AT&amp;T should still offer a hearty yield of around 5%.</p><p><img src=\"https://static.tigerbbs.com/ab366a5444f328185236645a8d066233\" tg-width=\"700\" tg-height=\"465\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/></p><h2>Enterprise Products Partners: 7.9% yield</h2><p>With the economic chaos caused by the pandemic still fresh in many investors&#39; minds, the idea of an oil stock providing &#34;safety&#34; to a portfolio during a crash might be laughable. But most oil and gas companies can&#39;t hold a candle to <b>Enterprise Products Partners</b> (NYSE:EPD) and its nearly 8% yield.</p><p>When crude oil demand experienced a historic drawdown in 2020, most upstream companies (drillers and explorers) were slammed. Enterprise Products Partners is a midstream company. It owns around 50,000 miles of oil and gas transmission pipeline, 19 natural gas processing facilities, and has approximately 14 billion cubic feet of natural gas storage space.</p><p>The beauty of this operating model can be seen in the way the company structures its contracts with drillers. With volume and price commitments in place well in advance, Enterprise Products Partners has a good bead on how much cash flow it&#39;ll be generating looking out multiple quarters. This cash flow predictability is the key to undertaking new infrastructure projects without compromising its profitability or 23-year streak of increasing its base annual payout.</p><p>It&#39;s also worth noting that at no point during the crash in crude oil prices in 2020 was Enterprise Products Partners&#39; dividend in danger of being cut.</p><p><img src=\"https://static.tigerbbs.com/b7c96011fb6b25a1831f75e74ea29790\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/></p><h2>Philip Morris International: 4.8% yield</h2><p>Another high-yield dividend stock that can save your portfolio during a stock market crash is global tobacco giant <b>Philip Morris International</b> (NYSE:PM). Philip Morris sports a yield of nearly 5%, with management intent on paying out a significant portion of annual profits as a dividend.</p><p>Three factors are responsible for making this company such a rock-solid investment in virtually any economic environment. First off, tobacco contains nicotine, which is an addictive chemical. These addictive properties allow the company to pass along price increases that help it outpace any volume declines it might be contending with in developed markets.</p><p>Second, Philip Morris&#39; geographic diversity is playing a big role. This is a company that&#39;s operating in more than 180 countries worldwide. If regulations are tightening in one market, chances are a burgeoning middle class looking for simple luxuries, like tobacco products, are making up the difference in an emerging market.</p><p>And third, Philip Morris is looking beyond its traditional tobacco lineup with its IQOS heated tobacco system. Through the first nine months of 2021, it held a close to 7% share of the heated tobacco market in countries where IQOS is sold (excluding the U.S.).</p><p><img src=\"https://static.tigerbbs.com/4a7ee02d220d347caebe42156ebb3644\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/></p><h2><a href=\"https://laohu8.com/S/NLY\">Annaly Capital Management</a>: 11.3% yield</h2><p>Among ultra-high-yield stocks, few can provide more stability to your portfolio during a stock market crash than mortgage real estate investment trust (REIT) <b>Annaly Capital Management</b> (NYSE:NLY). Annaly has paid out north of $20 billion in dividends over the past quarter of a century and has averaged a yield of around 10% for the past two decades.</p><p>Mortgage REITs like Annaly are attempting to borrow money at low, short-term lending rates, then using this capital to purchase higher-yielding long-term assets, like mortgage-backed securities. The difference between the yield the company receives and its average borrowing rate is known as &#34;net interest margin.&#34; The larger the net interest margin (NIM), the more profitable Annaly can be.</p><p>The good news here is Annaly has hit the sweet spot of its growth cycle. During the early stage of economic recoveries, it&#39;s not uncommon for the yield curve to steepen. When this difference in yield between short-and-long-term Treasury bonds widens, the company&#39;s NIM tends to rise.</p><p>What&#39;s more, over 90% of Annaly&#39;s asset portfolio is agency securities. These are assets backed by the federal government in the event of default. This added protection is what allows the company to deploy leverage to maximize profits and maintain its double-digit yield.</p><p><img src=\"https://static.tigerbbs.com/b18b49b2b35da2fc49e0a83b883d1c22\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/></p><h2>AbbVie: 4.1% yield</h2><p>A fifth high-yield dividend stock that can save your portfolio if a market crash strikes is pharmaceutical stock <b>AbbVie</b> (NYSE:ABBV). Although AbbVie&#39;s 4% yield pales in comparison to the likes of Annaly, bear in mind that the former&#39;s share price has more than doubled over the past 2.5 years.</p><p>There&#39;s little question that anti-inflammatory drug Humira is the superstar of AbbVie&#39;s product portfolio. Through the first nine months of 2021, Humira brought in $15.4 billion of the company&#39;s $41.2 billion in net product sales.  If not for the COVID-19 vaccines, Humira would be the world&#39;s top-selling drug. Despite facing biosimilar competition in Europe, Humira can remain AbbVie&#39;s cash cow for years to come.</p><p>On top of organic innovation, AbbVie hasn&#39;t been afraid to turn to acquisitions to diversify its revenue stream and boost its long-term growth potential. In May 2020, the company made a splash with its cash-and-stock deal to acquire Allergan. This deal added new lines of revenue (e.g., aesthetics and eye care), as well as a brand-name blockbuster in Botox.</p><p>Since people don&#39;t get to choose when they get sick or what ailment(s) they develop, demand for pharmaceuticals tends to remain steady in any economic environment. That makes healthcare stocks like AbbVie a solid bet to outperform during a market crash.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 High-Yield Dividend Stocks That Can Save Your Portfolio During a Stock Market Crash</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 High-Yield Dividend Stocks That Can Save Your Portfolio During a Stock Market Crash\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-01 21:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/02/01/5-high-yield-dividend-stocks-save-portfolio-crash/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>January provided a not-so-subtle reminder that stock market crashes and corrections are a normal part of the investing cycle, and they can occur without warning. Both the benchmark S&P 500 and growth ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/02/01/5-high-yield-dividend-stocks-save-portfolio-crash/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ABBV":"艾伯维公司","NIM":"纽文精选市政基金","BK4515":"5G概念","BK4144":"石油与天然气的储存和运输","BK4507":"流媒体概念","BK4534":"瑞士信贷持仓","BK4139":"生物科技","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4075":"烟草","BK4566":"资本集团","NLY":"Annaly Capital Management","BK4559":"巴菲特持仓","BK4550":"红杉资本持仓","EPD":"Enterprise Products Partners L.P","BK4115":"综合电信业务","REIT":"ALPS Active REIT ETF","BK4561":"索罗斯持仓","BK4110":"抵押房地产投资信托","T":"美国电话电报","PM":"菲利普莫里斯"},"source_url":"https://www.fool.com/investing/2022/02/01/5-high-yield-dividend-stocks-save-portfolio-crash/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2208633473","content_text":"January provided a not-so-subtle reminder that stock market crashes and corrections are a normal part of the investing cycle, and they can occur without warning. Both the benchmark S&P 500 and growth stock-driven Nasdaq Composite endured their steepest corrections in close to two years.While steep moves lower in the market in a short time frame can be unnerving, arguably one of the smartest ways to save your portfolio from these periods of heightened volatility is to buy high-yield dividend stocks (i.e., those with yields of 4% or above).Dividend stocks offer a number of advantages to investors. For instance, companies that pay a dividend are often profitable on a recurring basis and time-tested. Additionally, income stocks have a rich history of handily outperforming their non-dividend-paying peers.Image source: Getty Images.If this recent sell-off does turn into a full-blown stock market crash, the following high-yield dividend stocks can be your saviors.AT&T: 8.3% yieldIf you crave stability, telecom stocks like AT&T (NYSE:T) are a good place to find it. AT&T has two key catalysts that can deliver modest organic growth over the next half decade, all while the company parses out an above-average payout.For starters, ongoing upgrades to 5G wireless infrastructure are going to be a big deal. Even though the investments AT&T is making in wireless infrastructure are sizable, consumers and businesses have been waiting a decade for an upgrade to wireless download speeds. The rollout of 5G speeds in the U.S. should encourage businesses and consumers to replace their devices over the coming years. Since data is what drives AT&T's juicy wireless margins, faster download speeds can increase the wireless segment growth rate.The other growth catalyst for AT&T is the expected spinoff of content arm WarnerMedia, which will be merged with Discovery. This new media entity will offer a larger content library with over 85 million pro forma subscribers, and should result in at least $3 billion in annual cost synergies. Most importantly, AT&T will be able to modestly reduce its dividend following the spinoff and focus on debt reduction. Even after this dividend cut, AT&T should still offer a hearty yield of around 5%.Enterprise Products Partners: 7.9% yieldWith the economic chaos caused by the pandemic still fresh in many investors' minds, the idea of an oil stock providing \"safety\" to a portfolio during a crash might be laughable. But most oil and gas companies can't hold a candle to Enterprise Products Partners (NYSE:EPD) and its nearly 8% yield.When crude oil demand experienced a historic drawdown in 2020, most upstream companies (drillers and explorers) were slammed. Enterprise Products Partners is a midstream company. It owns around 50,000 miles of oil and gas transmission pipeline, 19 natural gas processing facilities, and has approximately 14 billion cubic feet of natural gas storage space.The beauty of this operating model can be seen in the way the company structures its contracts with drillers. With volume and price commitments in place well in advance, Enterprise Products Partners has a good bead on how much cash flow it'll be generating looking out multiple quarters. This cash flow predictability is the key to undertaking new infrastructure projects without compromising its profitability or 23-year streak of increasing its base annual payout.It's also worth noting that at no point during the crash in crude oil prices in 2020 was Enterprise Products Partners' dividend in danger of being cut.Philip Morris International: 4.8% yieldAnother high-yield dividend stock that can save your portfolio during a stock market crash is global tobacco giant Philip Morris International (NYSE:PM). Philip Morris sports a yield of nearly 5%, with management intent on paying out a significant portion of annual profits as a dividend.Three factors are responsible for making this company such a rock-solid investment in virtually any economic environment. First off, tobacco contains nicotine, which is an addictive chemical. These addictive properties allow the company to pass along price increases that help it outpace any volume declines it might be contending with in developed markets.Second, Philip Morris' geographic diversity is playing a big role. This is a company that's operating in more than 180 countries worldwide. If regulations are tightening in one market, chances are a burgeoning middle class looking for simple luxuries, like tobacco products, are making up the difference in an emerging market.And third, Philip Morris is looking beyond its traditional tobacco lineup with its IQOS heated tobacco system. Through the first nine months of 2021, it held a close to 7% share of the heated tobacco market in countries where IQOS is sold (excluding the U.S.).Annaly Capital Management: 11.3% yieldAmong ultra-high-yield stocks, few can provide more stability to your portfolio during a stock market crash than mortgage real estate investment trust (REIT) Annaly Capital Management (NYSE:NLY). Annaly has paid out north of $20 billion in dividends over the past quarter of a century and has averaged a yield of around 10% for the past two decades.Mortgage REITs like Annaly are attempting to borrow money at low, short-term lending rates, then using this capital to purchase higher-yielding long-term assets, like mortgage-backed securities. The difference between the yield the company receives and its average borrowing rate is known as \"net interest margin.\" The larger the net interest margin (NIM), the more profitable Annaly can be.The good news here is Annaly has hit the sweet spot of its growth cycle. During the early stage of economic recoveries, it's not uncommon for the yield curve to steepen. When this difference in yield between short-and-long-term Treasury bonds widens, the company's NIM tends to rise.What's more, over 90% of Annaly's asset portfolio is agency securities. These are assets backed by the federal government in the event of default. This added protection is what allows the company to deploy leverage to maximize profits and maintain its double-digit yield.AbbVie: 4.1% yieldA fifth high-yield dividend stock that can save your portfolio if a market crash strikes is pharmaceutical stock AbbVie (NYSE:ABBV). Although AbbVie's 4% yield pales in comparison to the likes of Annaly, bear in mind that the former's share price has more than doubled over the past 2.5 years.There's little question that anti-inflammatory drug Humira is the superstar of AbbVie's product portfolio. Through the first nine months of 2021, Humira brought in $15.4 billion of the company's $41.2 billion in net product sales.  If not for the COVID-19 vaccines, Humira would be the world's top-selling drug. Despite facing biosimilar competition in Europe, Humira can remain AbbVie's cash cow for years to come.On top of organic innovation, AbbVie hasn't been afraid to turn to acquisitions to diversify its revenue stream and boost its long-term growth potential. In May 2020, the company made a splash with its cash-and-stock deal to acquire Allergan. This deal added new lines of revenue (e.g., aesthetics and eye care), as well as a brand-name blockbuster in Botox.Since people don't get to choose when they get sick or what ailment(s) they develop, demand for pharmaceuticals tends to remain steady in any economic environment. That makes healthcare stocks like AbbVie a solid bet to outperform during a market crash.","news_type":1},"isVote":1,"tweetType":1,"viewCount":578,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9091973784,"gmtCreate":1643768538374,"gmtModify":1676533853851,"author":{"id":"3582933493509774","authorId":"3582933493509774","name":"linghui","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582933493509774","authorIdStr":"3582933493509774"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9091973784","repostId":"2208359771","repostType":4,"repost":{"id":"2208359771","kind":"news","pubTimestamp":1643759992,"share":"https://ttm.financial/m/news/2208359771?lang=&edition=fundamental","pubTime":"2022-02-02 07:59","market":"us","language":"en","title":"Wall St Posts Gains after Choppy Session, Energy Index Hits New Peak","url":"https://stock-news.laohu8.com/highlight/detail?id=2208359771","media":"Reuters","summary":"* Exxon Mobil gains on strong results* UPS jumps on upbeat forecast* AT&T down on halving dividend* ","content":"<html><head></head><body><p>* Exxon Mobil gains on strong results</p><p>* UPS jumps on upbeat forecast</p><p>* AT&amp;T down on halving dividend</p><p>* Indexes rise: Dow 0.78%, S&amp;P 0.69%, Nasdaq 0.75%</p><p>All three Wall Street benchmarks advanced on Tuesday and the energy index closed at a record high, although seesaw trading reflected investor uncertainty about how to play the current market.</p><p>Recent sessions have been choppy, as the prospect of an aggressive rate-hike campaign by the U.S. Federal Reserve looms large and investors seek to position themselves accordingly - a task not made easy by lingering pandemic influences on the economy and geopolitical tension in Europe.</p><p>But despite losing 5.3% and 3.3% in January respectively, the S&amp;P 500 and the Dow have now recorded three straight days of gains, with the Nasdaq - which dropped 8.99% in the first month of 2022 - posting four positive sessions in the last five.</p><p>It did not look like that would happen earlier in the session, when all three benchmarks traded lower in the wake of data from the Labor Department and the ISM&#39;s purchasing managers&#39; index (PMI).</p><p>&#34;You&#39;re starting to see that there are a lot of investors who are concerned about valuations going forward, but there are others who are worried about growth, so it seems the wall of worry keeps on growing as the economy exits this pandemic,&#34; said Ed Moya, senior market analyst at OANDA.</p><p>Philadelphia Fed President Patrick Harker said on Tuesday it may be appropriate for the U.S. central bank to raise rates four times this year, while Atlanta Fed president Raphael Bostic said the Fed needs to act &#34;soon&#34; to control inflation expectations.</p><p>Traders are betting on five rate hikes this year, with some Wall Street analysts expecting seven hikes.</p><p>&#34;This will be the year when Fed will pull back support ... the markets will not be on steroids anymore and may go through a phase of detox,&#34; said Anu Gaggar, global investment strategist at Commonwealth Financial Network.</p><p>Geopolitical tensions added to market volatility, with Ukraine&#39;s president signing a decree to boost his armed forces by 100,000 troops over three years, as European leaders lined up to back him in a standoff with Russia and the United States demanded immediate Russian de-escalation.</p><p>The Dow Jones Industrial Average rose 273.38 points, or 0.78%, to 35,405.24, the S&amp;P 500 gained 30.99 points, or 0.69%, to 4,546.54 and the Nasdaq Composite added 106.12 points, or 0.75%, to 14,346.00.</p><p>Once again, energy led the major S&amp;P sectors, gaining 3.5% to close at a record high. The index is, by far, the best performer in 2022, up 23.2%, as U.S. crude hovers near a seven-year high.</p><p>Those strong energy prices helped Exxon Mobil Corp to post its biggest quarterly profit in seven years on Tuesday. Its stock jumped 6.4% as a result, to close above the $80-per-share mark for the first time since April 2019.</p><p>As of Tuesday, 184 S&amp;P 500 companies posted quarterly results, of which 78.8% reported earnings above analyst expectations, according to Refinitiv.</p><p>Google parent Alphabet Inc rose 1.7% ahead of quarterly results published after the bell. Amazon Inc and <a href=\"https://laohu8.com/S/FB\">Meta Platforms</a> Inc are also on deck later this week.</p><p>Of those which reported earlier on Tuesday, United Parcel Service Inc jumped 14.1% - its biggest <a href=\"https://laohu8.com/S/AONE.U\">one</a>-day gain in 18 months - after projecting 2022 revenue above market expectations.</p><p>AT&amp;T Inc dropped 4.2% after saying it will spin off WarnerMedia in a $43 billion transaction to merge its media properties with Discovery Inc and also cut its dividend by nearly half.</p><p>Volume on U.S. exchanges was 11.71 billion shares, compared with the 12.45 billion average for the full session over the last 20 trading days.</p><p>The S&amp;P 500 posted 18 new 52-week highs and one new low; the Nasdaq Composite recorded 43 new highs and 18 new lows.</p></body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall St Posts Gains after Choppy Session, Energy Index Hits New Peak</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall St Posts Gains after Choppy Session, Energy Index Hits New Peak\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-02 07:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/us-stocks-wall-st-posts-213756846.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>* Exxon Mobil gains on strong results* UPS jumps on upbeat forecast* AT&T down on halving dividend* Indexes rise: Dow 0.78%, S&P 0.69%, Nasdaq 0.75%All three Wall Street benchmarks advanced on Tuesday...</p>\n\n<a href=\"https://finance.yahoo.com/news/us-stocks-wall-st-posts-213756846.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4201":"综合性石油与天然气企业","BK4023":"应用软件","BK4516":"特朗普概念","BK4554":"元宇宙及AR概念","BK4532":"文艺复兴科技持仓","CGEM":"Cullinan Therapeutics","SANA":"Sana Biotechnology, Inc.","XOM":"埃克森美孚","BK4553":"喜马拉雅资本持仓","GOOGL":"谷歌A","LHDX":"Lucira Health, Inc.","BK4507":"流媒体概念","BK4534":"瑞士信贷持仓","GOOG":"谷歌","ONTF":"ON24, Inc.","BK4139":"生物科技","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4566":"资本集团","BK4007":"制药","APR":"Apria, Inc.","BK4525":"远程办公概念","BK4196":"保健护理服务","SPY":"标普500ETF","BK4082":"医疗保健设备","BK4559":"巴菲特持仓","BK4538":"云计算","BK4077":"互动媒体与服务","BK4527":"明星科技股","BK4550":"红杉资本持仓",".SPX":"S&P 500 Index","BK4503":"景林资产持仓","BK4561":"索罗斯持仓","T":"美国电话电报","BK4504":"桥水持仓","COMP":"Compass, Inc.","LABP":"Landos Biopharma, Inc.","BK4548":"巴美列捷福持仓","BK4514":"搜索引擎"},"source_url":"https://finance.yahoo.com/news/us-stocks-wall-st-posts-213756846.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2208359771","content_text":"* Exxon Mobil gains on strong results* UPS jumps on upbeat forecast* AT&T down on halving dividend* Indexes rise: Dow 0.78%, S&P 0.69%, Nasdaq 0.75%All three Wall Street benchmarks advanced on Tuesday and the energy index closed at a record high, although seesaw trading reflected investor uncertainty about how to play the current market.Recent sessions have been choppy, as the prospect of an aggressive rate-hike campaign by the U.S. Federal Reserve looms large and investors seek to position themselves accordingly - a task not made easy by lingering pandemic influences on the economy and geopolitical tension in Europe.But despite losing 5.3% and 3.3% in January respectively, the S&P 500 and the Dow have now recorded three straight days of gains, with the Nasdaq - which dropped 8.99% in the first month of 2022 - posting four positive sessions in the last five.It did not look like that would happen earlier in the session, when all three benchmarks traded lower in the wake of data from the Labor Department and the ISM's purchasing managers' index (PMI).\"You're starting to see that there are a lot of investors who are concerned about valuations going forward, but there are others who are worried about growth, so it seems the wall of worry keeps on growing as the economy exits this pandemic,\" said Ed Moya, senior market analyst at OANDA.Philadelphia Fed President Patrick Harker said on Tuesday it may be appropriate for the U.S. central bank to raise rates four times this year, while Atlanta Fed president Raphael Bostic said the Fed needs to act \"soon\" to control inflation expectations.Traders are betting on five rate hikes this year, with some Wall Street analysts expecting seven hikes.\"This will be the year when Fed will pull back support ... the markets will not be on steroids anymore and may go through a phase of detox,\" said Anu Gaggar, global investment strategist at Commonwealth Financial Network.Geopolitical tensions added to market volatility, with Ukraine's president signing a decree to boost his armed forces by 100,000 troops over three years, as European leaders lined up to back him in a standoff with Russia and the United States demanded immediate Russian de-escalation.The Dow Jones Industrial Average rose 273.38 points, or 0.78%, to 35,405.24, the S&P 500 gained 30.99 points, or 0.69%, to 4,546.54 and the Nasdaq Composite added 106.12 points, or 0.75%, to 14,346.00.Once again, energy led the major S&P sectors, gaining 3.5% to close at a record high. The index is, by far, the best performer in 2022, up 23.2%, as U.S. crude hovers near a seven-year high.Those strong energy prices helped Exxon Mobil Corp to post its biggest quarterly profit in seven years on Tuesday. Its stock jumped 6.4% as a result, to close above the $80-per-share mark for the first time since April 2019.As of Tuesday, 184 S&P 500 companies posted quarterly results, of which 78.8% reported earnings above analyst expectations, according to Refinitiv.Google parent Alphabet Inc rose 1.7% ahead of quarterly results published after the bell. Amazon Inc and Meta Platforms Inc are also on deck later this week.Of those which reported earlier on Tuesday, United Parcel Service Inc jumped 14.1% - its biggest one-day gain in 18 months - after projecting 2022 revenue above market expectations.AT&T Inc dropped 4.2% after saying it will spin off WarnerMedia in a $43 billion transaction to merge its media properties with Discovery Inc and also cut its dividend by nearly half.Volume on U.S. exchanges was 11.71 billion shares, compared with the 12.45 billion average for the full session over the last 20 trading days.The S&P 500 posted 18 new 52-week highs and one new low; the Nasdaq Composite recorded 43 new highs and 18 new lows.","news_type":1},"isVote":1,"tweetType":1,"viewCount":231,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}